April 2026
1. SHUOLIN L, Chuanyin L, Zhu M, Zhu T, et al
   Targeting E3 Ubiquitin Ligase Hrd1 Prevents Myocardial Ischemia-Reperfusion Injury Through Enhancing ALDH2 Enzymatic Activity.
   Circulation. 2026 Apr 17. doi: 10.1161/CIRCULATIONAHA.125.074399.
   

   >> Share

   
   
2. ZHUANG Z, Huang J, Chi H
   Letter by Zhuang et al Regarding Article, "Experiences of Stalking and Obtaining a Restraining Order Are Associated With Onset of Cardiovascular Events in Women: A Prospective Analysis in the Nurses' Health Study II".
   Circulation. 2026;153:e1117-e1118.
   

   >> Share

   
   
3. MURCHLAND AR, Koenen KC, Lawn RB
   Response by Murchland et al to Letter Regarding Article, "Experiences of Stalking and Obtaining a Restraining Order Are Associated With Onset of Cardiovascular Events in Women: A Prospective Analysis in the Nurses' Health Study II".
   Circulation. 2026;153:e1119-e1120.
   

   >> Share

   
   
4. STEPANIAN A, Jaffe IZ
   Response by Stepanian and Jaffe to Letters Regarding Article, "Ponatinib, but Not the New Abl-Kinase Inhibitor Asciminib, Activates Platelets, Leukocytes, and Endothelial Cell TNF Signaling to Induce Atherosclerotic Plaque Inflammation, Myocardial Inf
   Circulation. 2026;153:e1113-e1114.
   

   >> Share

   
   
5. ZHENG T, Yuan X, Liu H
   Letter by Zheng et al Regarding Article, "Ponatinib, But Not the New Abl-Kinase Inhibitor Asciminib, Activates Platelets, Leukocytes, and Endothelial Cell TNF Signaling to Induce Atherosclerotic Plaque Inflammation, Myocardial Infarction, and Stroke".
   Circulation. 2026;153:e1109-e1110.
   

   >> Share

   
   
6. XU X, Zhang S, Bao L
   Letter by Xu et al Regarding Article, "Ponatinib, But Not the New Abl-Kinase Inhibitor Asciminib, Activates Platelets, Leukocytes, and Endothelial Cell TNF Signaling to Induce Atherosclerotic Plaque Inflammation, Myocardial Infarction, and Stroke".
   Circulation. 2026;153:e1111-e1112.
   

   >> Share

   
   
7. LIU C, Li X
   Letter by Liu and Li Regarding Article, "Ponatinib, But Not the New Abl-Kinase Inhibitor Asciminib, Activates Platelets, Leukocytes, and Endothelial Cell TNF Signaling to Induce Atherosclerotic Plaque Inflammation, Myocardial Infarction, and Stroke".
   Circulation. 2026;153:e1107-e1108.
   

   >> Share

   
   
8. SCHRAMA TJ, Aengevaeren VL
   Disentangling the Relationship Between Exercise and Coronary Atherosclerosis: Wearable Training Data Are the Way Forward.
   Circulation. 2026;153:1023-1025.
   

   >> Share

   
   
9. KUYUCU I, Canavar OF, Dogruer RD, Altin AD, et al
   Correction to: Abstract 4367615: The Cardiovascular Paradox of Gout Prophylaxis: A Systematic Review and Meta-analysis.
   Circulation. 2026;153:e1116.
   

   >> Share

   
   
10. HOJBJERG LASSEN MC, Ostrominski JW, Claggett BL, Ndumele CE, et al
    Cardiovascular-Kidney-Metabolic Syndrome Stages, Echocardiographic Characteristics, and Heart Failure Risk: The Atherosclerosis Risk in Communities Study.
    Circulation. 2026 Apr 1. doi: 10.1161/CIRCULATIONAHA.125.077894.
    

    >> Share

    
    March 2026
11. LI L
    Myocardial Infarction, Precision-Engineered T Regulatory Cells to the Rescue.
    Circulation. 2026;153:998-1000.
    

    >> Share

    
    
12. ZHANG M, Qin Y, Zhou T, Liu M, et al
    Engineered Regulatory T Lymphocytes Promote Infarcted Heart Repair.
    Circulation. 2026;153:983-997.
    

    >> Share

    
    
13. LICHTENSTEIN AH, Khera A, Anderson CAM, Appel LJ, et al
    2026 Dietary Guidance to Improve Cardiovascular Health: A Scientific Statement From the American Heart Association.
    Circulation. 2026 Mar 31. doi: 10.1161/CIR.0000000000001435.
    

    >> Share

    
    
14. PIANO MR, Marcus GM, Aycock DM, Buckman J, et al
    Correction to: Alcohol Use and Cardiovascular Disease: A Scientific Statement From the American Heart Association.
    Circulation. 2026;153:e1106.
    

    >> Share

    
    
15. BELLAVIA A, Murphy SA
    Competing Risks in Cardiovascular Research: A Practical Perspective.
    Circulation. 2026;153:945-947.
    

    >> Share

    
    
16. HUNDEMER GL, Vaidya A
    Response by Hundemer and Vaidya to Letter Regarding Article, "Subclinical Primary Aldosteronism and Major Adverse Cardiovascular Events: A Longitudinal Population-Based Cohort Study".
    Circulation. 2026;153:e1053-e1054.
    

    >> Share

    
    
17. XU J, Sun Y
    Letter by Xu and Sun Regarding Article, "Subclinical Primary Aldosteronism and Major Adverse Cardiovascular Events: A Longitudinal Population-Based Cohort Study".
    Circulation. 2026;153:e1052.
    

    >> Share

    
    
18. VEMULAPALLI S, Pena Guerra K, Wojdyla D, Jones WS, et al
    Adaptive AI for Cardiovascular Event Adjudication: Cardiovascular Event Adjudication Across Different Definitions in the ODYSSEY OUTCOMES and EUCLID Trials.
    Circulation. 2026 Mar 30. doi: 10.1161/CIRCULATIONAHA.126.080072.
    

    >> Share

    
    
19. MARSTON NA, Bergmark BA, Prohaska TA, Moura FA, et al
    Effect of APOC3 Inhibition with Olezarsen on Coronary Atherosclerosis: Essence-TIMI 73b Imaging Study.
    Circulation. 2026 Mar 30. doi: 10.1161/CIRCULATIONAHA.126.080012.
    

    >> Share

    
    
20. HANNEMAN K, Alahmad B, Ghosh A, Khatana SAM, et al
    Nonoptimal Temperature and Cardiovascular Health: A Scientific Statement From the American Heart Association.
    Circulation. 2026 Mar 26. doi: 10.1161/CIR.0000000000001419.
    

    >> Share

    
    
21. SUN S, Zhang X, Yue H, Fan C, et al
    The Aldehyde Dehydrogenase 2 rs671 Variant Enhances Platelet Activation and Arterial Thrombosis.
    Circulation. 2026;153:902-921.
    

    >> Share

    
    
22. DENG KQ, Xu Z, Wang Q, Cai HH, et al
    Inhibition of Annexin A2 Facilitates PHB2-Mediated Mitophagy in Cardiomyocytes to Alleviate Cardiac Injury and Remodeling After Infarction.
    Circulation. 2026;153:826-844.
    

    >> Share

    
    
23. DHRUVA SS
    Role of High-Dose Influenza Vaccine in Reducing Cardiovascular Risk.
    Circulation. 2026;153:807-809.
    

    >> Share

    
    
24. WATSON KE, Fonarow GC
    The 2026 American College of Cardiology/American Heart Association Multisociety Guideline on the Management of Dyslipidemia: A More Precise-But More Complicated-Framework for Atherosclerotic Cardiovascular Disease Prevention and Treatment.
    Circulation. 2026 Mar 13. doi: 10.1161/CIRCULATIONAHA.126.079538.
    

    >> Share

    
    
25. ZHU X, Li W, Yu J
    Letter by Zhu et al Regarding Article, "Joint Exposure to Ozone and Temperature and Acute Myocardial Infarction Among Adults Aged 18 to 64 Years in the United States".
    Circulation. 2026;153:e913.
    

    >> Share

    
    
26. CHU L, Ma X, Chen K
    Response by Chu et al to Letter Regarding Article, "Joint Exposure to Ozone and Temperature and Acute Myocardial Infarction Among Adults Aged 18 to 64 Years in the United States".
    Circulation. 2026;153:e914-e915.
    

    >> Share

    
    
27. ARAIZA-GARAYGORDOBIL D, Garcia-Jimenez Y, Gopar-Nieto R
    Global Rounds Mexico: Improving Cardiovascular Health Through Integration.
    Circulation. 2026;153:696-698.
    

    >> Share

    
    
28. HE J, Zhu Y
    Correction to: Selective mRNA Translation: A New Player in Ferroptosis After Myocardial Infarction.
    Circulation. 2026;153:e909.
    

    >> Share

    
    
29. JARR KU, Peters A, Leeper NJ
    Microplastics and Nanoplastics: A New Perspective in Cardiovascular Prevention.
    Circulation. 2026;153:613-615.
    

    >> Share

    
    February 2026
30. JOYNT MADDOX KE, Reynolds HR, Adedinsewo D, Bushnell C, et al
    Forecasting the Burden of Cardiovascular Disease and Stroke in Women in the United States Through 2050: A Scientific Statement From the American Heart Association.
    Circulation. 2026 Feb 25. doi: 10.1161/CIR.0000000000001406.
    

    >> Share

    
    
31. XIE J, Cheng LM, Liu K
    Letter by Xie et al Regarding Article, "High-Volume Physical Activity and Clinical Coronary Artery Disease Outcomes: Findings From the Cooper Center Longitudinal Study".
    Circulation. 2026;153:e109-e110.
    

    >> Share

    
    
32. HUANG J, Fogacci F
    Letter by Huang and Fogacci Regarding Article, "High-Volume Physical Activity and Clinical Coronary Artery Disease Outcomes: Findings From the Cooper Center Longitudinal Study".
    Circulation. 2026;153:e111-e112.
    

    >> Share

    
    
33. BERRY JD, Leonard D, Levine BD, DeFina LF, et al
    Response by Berry et al to Letter Regarding Article, "High-Volume Physical Activity and Clinical Coronary Artery Disease Outcomes: Findings From the Cooper Center Longitudinal Study".
    Circulation. 2026;153:e113-e114.
    

    >> Share

    
    
34. CARNETHON MR, Post WS, Hill JA, Al-Khatib SM, et al
    Go(ing) Red for Women and Fulfilling Our Commitment to Sex-Based Reporting of Cardiovascular Disease.
    Circulation. 2026;153:467-468.
    

    >> Share

    
    
35. GRAGNANO F, Giacoppo D, Choi KH, Kimura T, et al
    Clopidogrel Versus Aspirin Monotherapy in Coronary Artery Disease: A Sex-Stratified Individual Patient Data Meta-Analysis of Randomized Trials.
    Circulation. 2026;153:543-546.
    

    >> Share

    
    
36. ROSEN SE
    Redefining Cardiovascular Medicine: The Journey From "Does Sex Matter?" to "How Does Sex Matter?".
    Circulation. 2026;153:534-535.
    

    >> Share

    
    
37. BOYER TM, Barrett RB, Xiong C, Bu F, et al
    Hypertensive Disorders of Pregnancy and Premature Cardiovascular Disease in a Diverse Cohort of Young US Women.
    Circulation. 2026;153:480-492.
    

    >> Share

    
    
38. LI N, Hao Z, Yang H, Cai J, et al
    CCR8 Expression on Regulatory T Cells Reveals Trajectories of Tissue Adaptation and Protects Against Myocardial Infarction-Induced Tissue Damage.
    Circulation. 2026 Feb 13. doi: 10.1161/CIRCULATIONAHA.125.076426.
    

    >> Share

    
    
39. DARDARI ZA, Yao Z, Zhang J, Bakoyannis G, et al
    Prospective Associations of Obesity and Obesity Severity With 9 Cardiovascular Outcomes: The Cross-Cohort Collaboration.
    Circulation. 2026 Feb 12. doi: 10.1161/CIRCULATIONAHA.125.075327.
    

    >> Share

    
    
40. BAI X, Ren R, Yuan J, Yu L, et al
    Macrophage PRMT9 Ameliorates Acute Myocardial Infarction by Promoting Symmetric Dimethylation and Degradation of STAT1.
    Circulation. 2026 Feb 11. doi: 10.1161/CIRCULATIONAHA.125.076101.
    

    >> Share

    
    
41. KHAN SS, Greenland P, Hayman LL, Khera R, et al
    Criteria to Assess the Predictive and Clinical Utility of Novel Models, Biomarkers, and Tools for Risk of Cardiovascular Disease: A Scientific Statement From the American Heart Association.
    Circulation. 2026 Feb 11. doi: 10.1161/CIR.0000000000001401.
    

    >> Share

    
    
42. MADHAVAN MV, Gregson J, Redfors B, Chen S, et al
    Spontaneous Myocardial Infarction After Left Main Revascularization: The EXCEL Trial.
    Circulation. 2026 Feb 10. doi: 10.1161/CIRCULATIONAHA.125.075875.
    

    >> Share

    
    
43. ZHAO L, Zhao C, Wang Y
    Letter by Zhao et al Regarding Article, "Causal Relevance of Lp(a) for Coronary Heart Disease and Stroke Types in East Asian and European Ancestry Populations: A Mendelian Randomization Study".
    Circulation. 2026;153:e71-e72.
    

    >> Share

    
    
44. HUANG Q, Jian X, Wu F
    Letter by Huang et al Regarding Article, "Causal Relevance of Lp(a) for Coronary Heart Disease and Stroke Types in East Asian and European Ancestry Populations: A Mendelian Randomization Study".
    Circulation. 2026;153:e69-e70.
    

    >> Share

    
    
45. WU Y, Nguyen T, Wang Y, Zhou Y, et al
    Cardiomyocyte-Specific modRNA-Induced FoxM1 Overexpression Promotes Recovery From Myocardial Infarction in Adult Mammals.
    Circulation. 2026;153:463-466.
    

    >> Share

    
    
46. RHEE JW, Bolton KL, Gupta D, Weeks LD, et al
    Clonal Hematopoiesis and Its Cardiovascular Implications: A Scientific Statement From the American Heart Association.
    Circulation. 2026 Feb 10. doi: 10.1161/CIR.0000000000001404.
    

    >> Share

    
    
47. VON HUNDELSHAUSEN P, Siess W, Duan R, Bohnert T, et al
    Involvement of Btk in Cardiovascular Disease and Its Therapeutic Targeting.
    Circulation. 2026;153:435-456.
    

    >> Share

    
    
48. ZHANG L, Iliescu C, Ferencik M, Finamore V, et al
    Coronary Atherosclerosis in Patients With Cancer and Survivors: A Scientific Statement From the American Heart Association.
    Circulation. 2026 Feb 9. doi: 10.1161/CIR.0000000000001391.
    

    >> Share

    
    
49. LI X, Li X, Li CX, Feng J, et al
    TRPM7 Deficiency Protects Against Myocardial Ischemia-Reperfusion Injury by Regulating Intracellular Zn(2+) Homeostasis.
    Circulation. 2026 Feb 6. doi: 10.1161/CIRCULATIONAHA.125.074791.
    

    >> Share

    
    
50. BANGALORE S, Fearon WF, Fugar S, Dangas GD, et al
    Evidence-Based Practices in the Cardiac Catheterization Laboratory: Invasive Epicardial Coronary Physiologic Assessment: A Scientific Statement From the American Heart Association.
    Circulation. 2026;153:e25-e41.
    

    >> Share

    
    
51. KOVACIC JC, Reynolds HR, Alasnag M, Blakeman JR, et al
    Acute Coronary Syndromes in Premenopausal Women: A Scientific Statement From the American Heart Association.
    Circulation. 2026 Feb 3. doi: 10.1161/CIR.0000000000001416.
    

    >> Share

    
    January 2026
52. PAUWELS R, Dausin C, Ruiz-Carmona S, De Bosscher R, et al
    Wearable-Derived Training Load and Coronary Atherosclerosis in Middle-Aged and Older Athletes and Physically Active Controls: A New Perspective From the Master@Heart Study.
    Circulation. 2026 Jan 29. doi: 10.1161/CIRCULATIONAHA.125.077117.
    

    >> Share

    
    
53. CHANG Q, Li C, Xu Z
    An Atypical Presentation of an Occlusion Myocardial Infarction Requiring Urgent Revascularization.
    Circulation. 2026;153:282-284.
    

    >> Share

    
    
54. ARMSTRONG A, Pugh D, Basu N, Dhaun N, et al
    Current and Future Treatments for Takayasu Arteritis: Toward Cardiovascular Risk Modification.
    Circulation. 2026;153:266-281.
    

    >> Share

    
    
55. CHO Y, Kang D, Lim H, Lee H, et al
    Association of Statin Discontinuation in Pregnancy With Maternal Cardiovascular Health and Birth Outcomes: A Nationwide Cohort Study.
    Circulation. 2026 Jan 23. doi: 10.1161/CIRCULATIONAHA.125.078919.
    

    >> Share

    
    
56. HE J, Zhu Y
    Selective mRNA Translation: A New Player in Ferroptosis After Myocardial Infarction.
    Circulation. 2026;153:185-188.
    

    >> Share

    
    
57. PYRPYRIS N, Dimitriadis K, Tsioufis K
    Letter by Pyrpyris et al Regarding Article, "Nonculprit Vulnerable Plaques and Prognosis in Myocardial Infarction With Versus Without ST-Segment Elevation: A PROSPECT II Substudy".
    Circulation. 2026;153:e14-e15.
    

    >> Share

    
    
58. MAENG M, Thrane PG, Erlinge D, Maehara A, et al
    Response by Maeng et al to Letters Regarding Article, "Nonculprit Vulnerable Plaques and Prognosis in Myocardial Infarction With Versus Without ST-Segment Elevation: A PROSPECT II Substudy".
    Circulation. 2026;153:e17-e18.
    

    >> Share

    
    
59. SUN P
    Letter by Sun Regarding Article, "Nonculprit Vulnerable Plaques and Prognosis in Myocardial Infarction With Versus Without ST-Segment Elevation: A PROSPECT II Substudy".
    Circulation. 2026;153:e16.
    

    >> Share

    
    
60. SONG N, Beyene TJ, Amponsah DK, Asch SM, et al
    Correction to: Novel Use of Z Codes to Identify Social Determinants of Cardiovascular Disease Outcomes.
    Circulation. 2026;153:e19.
    

    >> Share

    
    
61. MUNZEL T, Luscher T, Kramer CM, Churchwell K, et al
    Environmental Stressors and Cardiovascular Health: Acting Locally for Global Impact in a Changing World: A Statement of the European Society of Cardiology, the American College of Cardiology, the American Heart Association, and the World Heart Federat
    Circulation. 2026 Jan 20. doi: 10.1161/CIRCULATIONAHA.125.079034.
    

    >> Share

    
    
62. LAU ES, D'Souza V, Zhao Y, Reeder C, et al
    Correction to: Contemporary Burden of Cardiovascular Disease in Pregnancy: Insights From a Real-World Pregnancy Electronic Health Record Cohort.
    Circulation. 2026;153:e11.
    

    >> Share

    
    
63. SITTICHOKKANANON A, Garfield V, Chiesa ST
    Response by Sittichokkananon et al to Letter Regarding Article, "Genetic and Lifestyle Risks for Coronary Artery Disease and Long-Term Risk of Incident Dementia Subtypes".
    Circulation. 2026;153:e6-e7.
    

    >> Share

    
    
64. YANG S, Lu Y
    Letter by Yang and Lu Regarding Article, "Genetic and Lifestyle Risks for Coronary Artery Disease and Long-Term Risk of Incident Dementia Subtypes".
    Circulation. 2026;153:e4-e5.
    

    >> Share

    
    
65. ZHAO YT
    Letter by Zhao Regarding Article, "Oral Semaglutide and Cardiovascular Outcomes in People With Type 2 Diabetes, According to SGLT2i Use: Prespecified Analyses of the SOUL Randomized Trial".
    Circulation. 2026;153:e8-e9.
    

    >> Share

    
    
66. FEARON WF, Terada K, Takahashi K, Skoda A, et al
    Cardiac Allograft Vasculopathy Inhibition With Alirocumab: The CAVIAR Trial.
    Circulation. 2026;153:7-17.
    

    >> Share

    
    
67. LEONARDI S, Landi A, Zito A, Branca M, et al
    Prognostic Implications of Evolving Universal Definitions of Periprocedural Myocardial Infarction in Patients With Acute Coronary Syndrome.
    Circulation. 2026 Jan 6. doi: 10.1161/CIRCULATIONAHA.125.077174.
    

    >> Share

    
    December 2025
68. GUNAWARDENE MA, Schmidt B, Peichl P, Nair D, et al
    Life-Threatening Delayed Myocardial Ischemia and Malignant Arrhythmias Occurring After Pulsed Field Ablation of Atrial Fibrillation.
    Circulation. 2025 Dec 25. doi: 10.1161/CIRCULATIONAHA.125.077983.
    

    >> Share

    
    
69. HENRIKSEN PA
    Challenges of Clinical Trials in Cardio-Oncology: Navigating Surrogate Outcomes and Identifying Patients at Risk of Late Cardiovascular Complications.
    Circulation. 2025;152:1756-1758.
    

    >> Share

    
    
70. TRAN AH, Zaidi AH, Bolger AF, Del Brutto OH, et al
    Periodontal Disease and Atherosclerotic Cardiovascular Disease: A Scientific Statement From the American Heart Association.
    Circulation. 2025 Dec 16. doi: 10.1161/CIR.0000000000001390.
    

    >> Share

    
    
71. XU L, Hrybouski S, Liao TE, Dong JN, et al
    Geometric Features of Ventricular Tachycardia Corridors in Patients With Ischemic Cardiomyopathy.
    Circulation. 2025;152:1608-1620.
    

    >> Share

    
    
72. SHARIF A
    Why We Must Rethink Kidney Transplantation as a Cardiovascular Risk-Reducing Intervention in Kidney Failure.
    Circulation. 2025;152:1591-1593.
    

    >> Share

    
    
73. TOMCZYK M, Kraszewska I, Li G, Hayes MJ, et al
    Chordin-Like 1 mRNA Therapy for Acute Myocardial Infarction.
    Circulation. 2025;152:1586-1589.
    

    >> Share

    
    
74. RAJKUMAR CA, Foley MJ, Ahmed-Jushuf F, Chotai S, et al
    The Role of the Collateral Circulation in Stable Angina: An Invasive Placebo-Controlled Study.
    Circulation. 2025;152:1541-1551.
    

    >> Share

    
    
75. FETTERMAN JL, Chinnery PF, McClellan R, Wallace DC, et al
    Mitochondrial Genetics in Cardiovascular Health and Disease: A Scientific Statement From the American Heart Association.
    Circulation. 2025 Dec 2. doi: 10.1161/CIR.0000000000001393.
    

    >> Share

    
    
76. TSIMIKAS S, Szarek M, Cobbaert CM, Romijn F, et al
    Oxidized Phospholipids, Lipoprotein(a), and Cardiovascular Outcomes after Acute Coronary Syndrome.
    Circulation. 2025 Dec 1. doi: 10.1161/CIRCULATIONAHA.125.073855.
    

    >> Share

    
    November 2025
77. CHEN Y
    Letter by Chen Regarding Article, "Dose Response of Incidental Physical Activity Against Cardiovascular Events and Mortality".
    Circulation. 2025;152:e407.
    

    >> Share

    
    
78. TULETA I, Venugopal H, O'Leary K, Zheng D, et al
    Fibroblast-Specific Loss of TGF-beta Signaling Mediates Lipomatous Metaplasia in the Infarcted Heart.
    Circulation. 2025;152:1423-1435.
    

    >> Share

    
    
79. DAMLUJI AA, Nanna MG, Mason P, Lowenstern A, et al
    Coronary Artery Revascularization in the Older Adult Population: A Scientific Statement From the American Heart Association.
    Circulation. 2025 Nov 18. doi: 10.1161/CIR.0000000000001387.
    

    >> Share

    
    
80. LANDSTROM AP, Ferguson JF, James CA, Key KV, et al
    Genetic and Genomic Testing in Cardiovascular Disease: A Policy Statement From the American Heart Association.
    Circulation. 2025 Nov 13. doi: 10.1161/CIR.0000000000001385.
    

    >> Share

    
    
81. RAO SV, O'Donoghue ML, Ruel M, Rab T, et al
    Correction to: 2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
    Circulation. 2025;152:e402.
    

    >> Share

    
    
82. OHAYON-STECKEL L, Zhang X, Haque S, Uddin MA, et al
    miR-499 in Platelet-Derived Extracellular Vesicles Augments Inflammatory Cell Generation and Cardiac Remodeling After Myocardial Infarction.
    Circulation. 2025 Nov 10. doi: 10.1161/CIRCULATIONAHA.124.073527.
    

    >> Share

    
    
83. DUDUM R, Jain SS, Mastrodicasa D, Furst A, et al
    Effects of Real-Time Notification of AI-Detected Incidental Coronary Artery Calcium on Statin Prescription: the NOTIFY-PICTURE Trial.
    Circulation. 2025 Nov 10. doi: 10.1161/CIRCULATIONAHA.125.078155.
    

    >> Share

    
    
84. JOHANSEN ND, Modin D, Pardo-Seco J, Rodriguez-Tenreiro-Sanchez C, et al
    High-Dose vs. Standard-Dose Influenza Vaccine and Cardiovascular Outcomes in Older Adults: The FLUNITY-HD Prespecified Pooled Analysis.
    Circulation. 2025 Nov 10. doi: 10.1161/CIRCULATIONAHA.125.077801.
    

    >> Share

    
    
85. SLIPCZUK L, Blankstein R, Bucciarelli-Ducci C, Braun LT, et al
    State of the Art: Evaluation and Medical Management of Nonobstructive Coronary Artery Disease in Patients With Chest Pain: A Scientific Statement From the American Heart Association.
    Circulation. 2025 Nov 10. doi: 10.1161/CIR.0000000000001394.
    

    >> Share

    
    
86. LEMESLE G, Didier R, Diallo A, Dromas H, et al
    Anticoagulation and Antiplatelet Therapy Versus Anticoagulation Alone in Patients With Chronic Coronary Syndrome Receiving Long-term Anticoagulation: a Meta-analysis of Randomized Clinical Trials.
    Circulation. 2025 Nov 8. doi: 10.1161/CIRCULATIONAHA.125.077141.
    

    >> Share

    
    
87. RAPOSEIRAS ROUBIN S, Abu Assi E, Jimenez Mendez C, Minguez de la Guia E, et al
    Triple Versus Dual Lipid-Lowering Therapy in Acute Coronary Syndrome: The ES-BempeDACS Randomized Clinical Trial.
    Circulation. 2025 Nov 7. doi: 10.1161/CIRCULATIONAHA.125.075388.
    

    >> Share

    
    
88. WANG J, Yang Bennett DS, Echard EJ, Chen B, et al
    Correction to: Junctophilin-2 Regulates Store-Operated Calcium Entry to Drive Cardiac Fibroblast Activation, Fibrotic Repair, and Angiogenesis After Myocardial Infarction.
    Circulation. 2025;152:e371.
    

    >> Share

    
    October 2025
89. RUEL M
    Introduction to the 2025 Cardiovascular Surgery-Themed Issue of Circulation.
    Circulation. 2025;152:1187.
    

    >> Share

    
    
90. DONOGHUE AJ, Auerbach M, Banerjee A, Blewer AL, et al
    Part 12: Resuscitation Education Science: 2025 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.
    Circulation. 2025;152.
    

    >> Share

    
    
91. HIRSCH KG, Amorim E, Coppler PJ, Drennan IR, et al
    Part 11: Post-Cardiac Arrest Care: 2025 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.
    Circulation. 2025;152.
    

    >> Share

    
    
92. DEL RIOS M, Bartos JA, Panchal AR, Atkins DL, et al
    Part 1: Executive Summary: 2025 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.
    Circulation. 2025;152.
    

    >> Share

    
    
93. PANCHAL AR, Bartos JA, Wyckoff MH, Drennan IR, et al
    Part 2: Evidence Evaluation and Guidelines Development: 2025 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.
    Circulation. 2025;152.
    

    >> Share

    
    
94. JOYNER BL JR, Dewan M, Bavare A, de Caen A, et al
    Part 6: Pediatric Basic Life Support: 2025 American Heart Association and American Academy of Pediatrics Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.
    Circulation. 2025;152.
    

    >> Share

    
    
95. ELMER J, Atkins DL, Daya MR, Del Rios M, et al
    Part 3: Ethics: 2025 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.
    Circulation. 2025;152.
    

    >> Share

    
    
96. CAO D, Arens AM, Chow SL, Easter SR, et al
    Part 10: Adult and Pediatric Special Circumstances of Resuscitation: 2025 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.
    Circulation. 2025;152.
    

    >> Share

    
    
97. KLEINMAN ME, Buick JE, Huber N, Idris AH, et al
    Part 7: Adult Basic Life Support: 2025 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.
    Circulation. 2025;152.
    

    >> Share

    
    
98. LEE HC, Strand ML, Finan E, Illuzzi J, et al
    Part 5: Neonatal Resuscitation: 2025 American Heart Association and American Academy of Pediatrics Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.
    Circulation. 2025;152.
    

    >> Share

    
    
99. DEZFULIAN C, Cabanas JG, Buckley JR, Cash RE, et al
    Part 4: Systems of Care: 2025 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.
    Circulation. 2025;152.
    

    >> Share

    
    
100. LASA JJ, Dhillon GS, Duff JP, Hayes J, et al
     Part 8: Pediatric Advanced Life Support: 2025 American Heart Association and American Academy of Pediatrics Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.
     Circulation. 2025;152.
     

     >> Share

     
     
101. WIGGINTON JG, Agarwal S, Bartos JA, Coute RA, et al
     Part 9: Adult Advanced Life Support: 2025 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.
     Circulation. 2025;152.
     

     >> Share

     
     
102. WINDFELD-MATHIASEN J, Heerfordt IM, Dalhoff KP, Andersen JT, et al
     Response by Windfeld-Mathiasen et al to Letter Regarding Article, "Cardiovascular Disease in Anabolic Androgenic Steroid Users".
     Circulation. 2025;152:e296-e297.
     

     >> Share

     
     
103. KING SJ, Furst A, Fan J, Chen TP, et al
     Comparison of the Pooled Cohort and the PREVENT Cardiovascular Disease Risk Equations in the Veterans Health Administration.
     Circulation. 2025;152:1183-1185.
     

     >> Share

     
     
104. KORNELIUS E
     Letter by Kornelius Regarding Article, "Cardiovascular Disease in Anabolic Androgenic Steroid Users".
     Circulation. 2025;152:e295.
     

     >> Share

     
     
105. KOLE A, Joshi PH
     Clear as Mud: Determining the Stage of Prevention in Cardiovascular Disease.
     Circulation. 2025;152:1123-1125.
     

     >> Share

     
     
106. REGAN JA, Laitner MH, Dzau VJ
     A Crossroads in Cardiovascular Medicine: Progress and Barriers to Impact.
     Circulation. 2025;152:1166-1173.
     

     >> Share

     
     
107. CHEN X, Yu X, Zhong S, Sha P, et al
     ALDH2/eIF3E Interaction Modulates Protein Translation Critical for Cardiomyocyte Ferroptosis in Acute Myocardial Ischemia Injury.
     Circulation. 2025 Oct 20. doi: 10.1161/CIRCULATIONAHA.125.075220.
     

     >> Share

     
     
108. FORAKER R, Sperling L, Bratzke L, Budoff M, et al
     Opportunistic Detection of Coronary Artery Calcium on Noncardiac Chest Computed Tomography: An Emerging Tool for Cardiovascular Disease Prevention: A Scientific Statement From the American Heart Association.
     Circulation. 2025 Oct 16. doi: 10.1161/CIR.0000000000001382.
     

     >> Share

     
     
109. KHAN SS, Fisher SA
     Bending the Curve in Maternal Mortality: Pregnancy as a Moment for Cardiovascular Disease Prevention.
     Circulation. 2025;152:1056-1059.
     

     >> Share

     
     
110. LAU ES, D'Souza V, Zhao Y, Reeder C, et al
     Contemporary Burden of Cardiovascular Disease in Pregnancy: Insights From a Real-World Pregnancy Electronic Health Record Cohort.
     Circulation. 2025;152:1044-1055.
     

     >> Share

     
     
111. OREN O, Libby P
     Incorporating Management of Clonal Hematopoiesis of Indeterminate Potential Into Cardiovascular Practice.
     Circulation. 2025;152:975-977.
     

     >> Share

     
     September 2025
112. VONGPATANASIN W, Abraham J, Giacona JM
     Subclinical Primary Aldosteronism: A Potential New Target in Cardiovascular Prevention?
     Circulation. 2025;152:924-926.
     

     >> Share

     
     
113. SECHI LA, Bulfone L, Catena C
     Letter by Sechi et al Regarding Article, "Independence of Lipoprotein(a) and Low-Density Lipoprotein Cholesterol-Medicated Cardiovascular Risk: A Participant-Level Meta-Analysis".
     Circulation. 2025;152:e265-e266.
     

     >> Share

     
     
114. BHATIA HS, Tsimikas S
     Response by Bhatia and Tsimikas to Letter Regarding Article, "Independence of Lipoprotein(a) and Low-Density Lipoprotein Cholesterol-Medicated Cardiovascular Risk: A Participant-Level Meta-Analysis".
     Circulation. 2025;152:e267-e268.
     

     >> Share

     
     
115. PETEK BJ, Churchill TW, Moulson N, Baggish AL, et al
     Sudden Cardiac Arrest and Death Secondary to Congenital Coronary Artery Abnormalities in Young Competitive Athletes.
     Circulation. 2025;152:971-973.
     

     >> Share

     
     
116. GENTILE F, Carapellucci E, Uggenti V, Lorenzoni V, et al
     Clinical and Prognostic Significance of Anomalous Origin of a Coronary Artery in Adults.
     Circulation. 2025 Sep 25. doi: 10.1161/CIRCULATIONAHA.125.074198.
     

     >> Share

     
     
117. MORI Y, Sawano M, Kohsaka S, Tsugawa Y, et al
     Screening-Detected Atrial Fibrillation and Cardiovascular Outcomes in Working-Age Adults.
     Circulation. 2025 Sep 25. doi: 10.1161/CIRCULATIONAHA.125.074433.
     

     >> Share

     
     
118. GAN J, Zhao R, Zheng D, Peng Y, et al
     PYGM Protects Against Myocardial Infarction by Enhancing Glycogenolysis and Facilitating Autophagic Flux.
     Circulation. 2025 Sep 24. doi: 10.1161/CIRCULATIONAHA.124.072312.
     

     >> Share

     
     
119. FENG S, Wang Z, Sun R
     Letter by Feng et al Regarding Article, "Association of Coagulation Factor XI Level With Cardiovascular Events and Cardiac Function in Community-Dwelling Adults: From ARIC and CHS".
     Circulation. 2025;152:e239-e240.
     

     >> Share

     
     
120. ZHONG Y, Lai R, Deng X
     Letter by Zhong et al Regarding Article, "Association of Coagulation Factor XI Level With Cardiovascular Events and Cardiac Function in Community-Dwelling Adults: From ARIC and CHS".
     Circulation. 2025;152:e241-e242.
     

     >> Share

     
     
121. JI Y, Chen LY, Zhang MJ
     Response by Ji et al to Letters Regarding Article, "Association of Coagulation Factor XI Level With Cardiovascular Events and Cardiac Function in Community-Dwelling Adults: From ARIC and CHS".
     Circulation. 2025;152:e243-e244.
     

     >> Share

     
     
122. LEVINE GN, Carney RM, Cohen BE, Dunn SL, et al
     Post-Myocardial Infarction Psychological Distress: A Scientific Statement From the American Heart Association.
     Circulation. 2025 Sep 22. doi: 10.1161/CIR.0000000000001381.
     

     >> Share

     
     
123. COUTINHO T
     The Geometry of Aging: New Angles on Cardiovascular Risk.
     Circulation. 2025;152:762-764.
     

     >> Share

     
     
124. HUDED CP, Spertus JA, Jones PG, O'Brien SM, et al
     Health Status Outcomes With Percutaneous Coronary Intervention and Coronary Artery Bypass Grafting in ISCHEMIA.
     Circulation. 2025 Sep 5. doi: 10.1161/CIRCULATIONAHA.125.073591.
     

     >> Share

     
     
125. SHI F, Zheng B, Liu Y
     Letter by Shi et al Regarding Article "Associations of Circulating ANGPTL3, C-Terminal Domain-Containing ANGPTL4, and ANGPTL3/8 and ANGPTL4/8 Complexes with LPL Activity, Diabetes, Inflammation, and Cardiovascular Mortality".
     Circulation. 2025;152:e71-e72.
     

     >> Share

     
     
126. NAMBI V, de Lemos JA, Ballantyne CM
     A Proposal to Elevate the Status of Troponin and B-Type Natriuretic Peptides as Atherosclerotic Cardiovascular Disease Risk Enhancers.
     Circulation. 2025;152:567-569.
     

     >> Share

     
     
127. KUEHN BM
     Microplastics Exposure Linked to Cardiovascular Disease Risk, Chronic Health Conditions.
     Circulation. 2025;152:630-631.
     

     >> Share

     
     
128. SILBERNAGEL G, Wen Y, Konrad RJ
     Response by Silbernagel et al to Letters Regarding Article, "Associations of Circulating ANGPTL3, C-Terminal Domain-Containing ANGPTL4, and ANGPTL3/8 and ANGPTL4/8 Complexes with LPL Activity, Diabetes, Inflammation, and Cardiovascular Mortality".
     Circulation. 2025;152:e73-e74.
     

     >> Share

     
     
129. HUANG J
     Letter by Huang Regarding Article, "Associations of Circulating ANGPTL3, C-Terminal Domain-Containing ANGPTL4, and ANGPTL3/8 and ANGPTL4/8 Complexes with LPL Activity, Diabetes, Inflammation, and Cardiovascular Mortality".
     Circulation. 2025;152:e69-e70.
     

     >> Share

     
     
130. CROON PM, Dhingra LS, Biswas D, Oikonomou EK, et al
     Phenotypic Selectivity of Artificial Intelligence-enhanced Electrocardiography in Cardiovascular Diagnosis and Risk Prediction.
     Circulation. 2025 Sep 1. doi: 10.1161/CIRCULATIONAHA.125.076279.
     

     >> Share

     
     August 2025
131. KHAN SS, Abdalla M, Bello NA, Blyler CA, et al
     Use of Risk Assessment to Guide Decision-Making for Blood Pressure Management in the Primary Prevention of Cardiovascular Disease: A Scientific Statement From the American Heart Association and American College of Cardiology.
     Circulation. 2025 Aug 28. doi: 10.1161/CIR.0000000000001355.
     

     >> Share

     
     
132. CHEN BY, Zhu H, Li YL, Zhang J, et al
     Oral Pathobionts Aggravate Myocardial Infarction Through Mobilization of B2 Cells.
     Circulation. 2025 Aug 27. doi: 10.1161/CIRCULATIONAHA.125.074837.
     

     >> Share

     
     
133. WU J, Zheng Y
     Letter by Wu and Zheng Regarding Article, "A Proteomics-Based Approach for Prediction of Different Cardiovascular Diseases and Dementia".
     Circulation. 2025;152:e67.
     

     >> Share

     
     
134. HO FK, Sattar N, Welsh P
     Response by Ho et al to Letter Regarding Article, "A Proteomics-Based Approach for Prediction of Different Cardiovascular Diseases and Dementia".
     Circulation. 2025;152:e68.
     

     >> Share

     
     
135. QIN D, Modanwal R, Ghazi M, Corbalan JJ, et al
     Reformulation of the Necroptosis Pathway in Reperfused Myocardial Infarction.
     Circulation. 2025;152:486-488.
     

     >> Share

     
     
136. BERRY C, Carberry J, Dharmakumar R
     Intramyocardial Hemorrhage After Myocardial Infarction: A Prognostic Outcome for Clinical Practice and Trials.
     Circulation. 2025;152:349-351.
     

     >> Share

     
     
137. VIDOT DC
     Up in Smoke: No Association Between Cannabis Smoking and Cardiovascular Events Among Older Military Veterans With Coronary Artery Disease.
     Circulation. 2025;152:366-368.
     

     >> Share

     
     
138. LAWN RB, Murchland AR, Thurston RC, Marquez C, et al
     Experiences of Stalking and Obtaining a Restraining Order Are Associated With Onset of Cardiovascular Events in Women: A Prospective Analysis in the Nurses' Health Study II.
     Circulation. 2025 Aug 11:10.1161/CIRCULATIONAHA.124.073592.
     

     >> Share

     
     
139. STEPANIAN A, Travers RJ, Tesfu A, Wolter NL, et al
     Ponatinib, But Not the New Abl-Kinase Inhibitor Asciminib, Activates Platelets, Leukocytes, and Endothelial Cell TNF Signaling to Induce Atherosclerotic Plaque Inflammation, Myocardial Infarction, and Stroke.
     Circulation. 2025 Aug 5. doi: 10.1161/CIRCULATIONAHA.125.073610.
     

     >> Share

     
     
140. BECKMAN JA, Drooz AT, Farber A, Hamdan A, et al
     The Impact of Coronary Artery Disease in Patients With Peripheral Artery Disease Undergoing Lower-Extremity Revascularization for Chronic Limb-Threatening Ischemia.
     Circulation. 2025;152:346-348.
     

     >> Share

     
     
141. TABAK RG, Kandula NR, Angell SY, Brewer LC, et al
     Implementation of Evidence-Based Behavioral Interventions for Cardiovascular Disease Prevention in Community Settings: A Scientific Statement From the American Heart Association.
     Circulation. 2025 Aug 4. doi: 10.1161/CIR.0000000000001349.
     

     >> Share

     
     July 2025
142. WERESKI R, Morrow DA, Mills NL
     Unstable Angina Refined.
     Circulation. 2025;152:213-216.
     

     >> Share

     
     
143. WANG Q, Ismahil MA, Zhu Y, Rokosh G, et al
     CD206(+)IL-4Ralpha(+) Macrophages Are Drivers of Adverse Cardiac Remodeling in Ischemic Cardiomyopathy.
     Circulation. 2025;152:257-273.
     

     >> Share

     
     
144. WANG J, Yang Bennett DS, Echard EJ, Chen B, et al
     Junctophilin-2 Regulates Store-Operated Calcium Entry to Drive Cardiac Fibroblast Activation, Fibrotic Repair, and Angiogenesis After Myocardial Infarction.
     Circulation. 2025 Jul 25. doi: 10.1161/CIRCULATIONAHA.125.073937.
     

     >> Share

     
     
145. KEYHANI S, Cohen BE, Vali M, Hoggatt KJ, et al
     Association of Smoking Cannabis With Cardiovascular Events Among Veterans With Coronary Artery Disease.
     Circulation. 2025 Jul 21. doi: 10.1161/CIRCULATIONAHA.124.073193.
     

     >> Share

     
     
146. CARBONNEAU M, Li Y, Qu Y, Zheng Y, et al
     DNA Methylation Signatures of Cardiovascular Health Provide Insights Into Diseases.
     Circulation. 2025 Jul 14:10.1161/CIRCULATIONAHA.124.073181.
     

     >> Share

     
     
147. BANN GG, Dos Santos M, Chen K, Tan W, et al
     Cellular Reprogramming by PHF7 Enhances Cardiac Function Following Myocardial Infarction.
     Circulation. 2025 Jul 9. doi: 10.1161/CIRCULATIONAHA.124.072733.
     

     >> Share

     
     
148. GOUPIL R, Desbiens LC, Merabtine A, Agharazii M, et al
     Subclinical Primary Aldosteronism and Major Adverse Cardiovascular Events: A Longitudinal Population-Based Cohort Study.
     Circulation. 2025 Jul 9:10.1161/CIRCULATIONAHA.124.073507.
     

     >> Share

     
     
149. HU Q, Zhang J, Luo X, Hu P, et al
     Intracellular L-PGDS-Derived 15d-PGJ2 Inhibits CaMKII Through Lipoxidation to Alleviate Cardiac Ischemia/Reperfusion Injury.
     Circulation. 2025;152:41-57.
     

     >> Share

     
     
150. HENDREN NS, Ammirati E
     Cardiovascular Effects of COVID-19: Legacy and Future Insights.
     Circulation. 2025;152:24-26.
     

     >> Share

     
     
151. CUEVAS C, Kikushima-Alcantara P, Miranda JJ
     The State of Cardiovascular Care in Peru: Needs for System Strengthening.
     Circulation. 2025;152:7-10.
     

     >> Share

     
     June 2025
152. GONG Y, Lu X, Wang X, Wang Y, et al
     Mitochondrial Tumor Suppressor 1A Attenuates Myocardial Infarction Injury by Maintaining the Coupling Between Mitochondria and Endoplasmic Reticulum.
     Circulation. 2025 Jun 30. doi: 10.1161/CIRCULATIONAHA.124.069737.
     

     >> Share

     
     
153. DUAN Z, Lin Z
     Response by Duan and Lin to Letter Regarding Article, "Bone Morphogenetic Protein 9 Protects Against Myocardial Infarction by Improving Lymphatic Drainage Function and Triggering DECR1-Mediated Mitochondrial Bioenergetics".
     Circulation. 2025;151:e1093-e1094.
     

     >> Share

     
     
154. THRANE PG, Maeng M, Maehara A, Botker HE, et al
     Nonculprit Vulnerable Plaques and Prognosis in Myocardial Infarction With Versus Without ST-Segment Elevation: A PROSPECT II Substudy.
     Circulation. 2025;151:1767-1779.
     

     >> Share

     
     
155. WANG H, Zhao T, Zheng G
     Letter by Wang et al Regarding Article, "Bone Morphogenetic Protein 9 Protects Against Myocardial Infarction by Improving Lymphatic Drainage Function and Triggering DECR1-Mediated Mitochondrial Bioenergetics".
     Circulation. 2025;151:e1091-e1092.
     

     >> Share

     
     
156. RAO SV, O'Donoghue ML, Ruel M, Rab T, et al
     Correction to: 2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
     Circulation. 2025;151:e1098.
     

     >> Share

     
     
157. BELLAVIA A, Murphy SA
     Confounders, Effect Modifiers, and Mediators: Dealing With "Third Variables" in Cardiovascular Epidemiology.
     Circulation. 2025;151:1755-1757.
     

     >> Share

     
     
158. JOHNY E, Dutta P
     Targeting Extramedullary Hematopoiesis and Cardiac Immune Homing to Encourage Cardiac Healing After Myocardial Infarction.
     Circulation. 2025;151:1748-1751.
     

     >> Share

     
     
159. ARNAOUT R
     From Bytes to Beats: Overcoming Conceptual and Implementation Challenges for AI in Cardiovascular Care.
     Circulation. 2025;151:1697-1698.
     

     >> Share

     
     
160. GRECO M, Lombardi G, Brusasco C, Pieri M, et al
     Effect of Remote Ischemic Preconditioning on Myocardial Injury in Noncardiac Surgery: the PRINCE Randomized Clinical Trial.
     Circulation. 2025 Jun 13. doi: 10.1161/CIRCULATIONAHA.125.075254.
     

     >> Share

     
     
161. CAMPO G, Pavasini R
     Response by Campo and Pavasini to Letter Regarding Article, "Complete Versus Culprit-Only Revascularization in Older Patients With ST-Segment-Elevation Myocardial Infarction: An Individual Patient Meta-Analysis".
     Circulation. 2025;151:e1049-e1050.
     

     >> Share

     
     
162. PAN D, Wu W, Chen M
     Letter by Pan et al Regarding Article, "Complete Versus Culprit-Only Revascularization in Older Patients With ST-Segment-Elevation Myocardial Infarction: An Individual Patient Meta-Analysis".
     Circulation. 2025;151:e1047-e1048.
     

     >> Share

     
     
163. PIANO MR, Marcus GM, Aycock DM, Buckman J, et al
     Alcohol Use and Cardiovascular Disease: A Scientific Statement From the American Heart Association.
     Circulation. 2025 Jun 9. doi: 10.1161/CIR.0000000000001341.
     

     >> Share

     
     
164. LEE S, Hwang SH, Park S, Son Y, et al
     Burden of Cardiovascular Outcomes After SARS-CoV-2 Infection in South Korea and Japan: A Binational Population-Based Cohort Study.
     Circulation. 2025 Jun 4. doi: 10.1161/CIRCULATIONAHA.125.073086.
     

     >> Share

     
     
165. OBEL LM, Skovbo JS, Diederichsen ACP, Thomassen M, et al
     Aortic Aneurysm Risk and Somatic JAK2(V617F)Variation: Insights From a Multicenter, Population-Based Cardiovascular Screening Study.
     Circulation. 2025 Jun 4. doi: 10.1161/CIRCULATIONAHA.125.074002.
     

     >> Share

     
     
166. CHU L, Wang R, Gross CP, Wei J, et al
     Joint Exposure to Ozone and Temperature and Acute Myocardial Infarction Among Adults Aged 18 to 64 Years in the United States.
     Circulation. 2025 Jun 3. doi: 10.1161/CIRCULATIONAHA.124.073614.
     

     >> Share

     
     
167. GREGSON J, Taylor D, Owen R, Collier T, et al
     Hierarchical Composite Outcomes and Win Ratio Methods in Cardiovascular Trials: A Review and Consequent Guidance.
     Circulation. 2025;151:1606-1619.
     

     >> Share

     
     May 2025
168. SCHNEEWEISS S, Kruger N
     Non-Randomized Database Analyses to Complement Randomized Clinical Trials: Promising Approaches for Cardiovascular Medicine.
     Circulation. 2025;151:1495-1497.
     

     >> Share

     
     
169. BERRY C, McCartney P
     Letter by Berry and McCartney Regarding Article, "Effect of Cangrelor on Infarct Size in ST-Segment-Elevation Myocardial Infarction Treated by Primary Percutaneous Coronary Intervention (The PITRI Trial)".
     Circulation. 2025;151:e1002-e1003.
     

     >> Share

     
     
170. BULLUCK H, Hausenloy DJ
     Response by Bulluck and Hausenloy to Letter Regarding Article, "Effect of Cangrelor on Infarct Size in ST-Segment-Elevation Myocardial Infarction Treated by Primary Percutaneous Coronary Intervention: A Randomized Controlled Trial (the PITRI Trial)".
     Circulation. 2025;151:e1004-e1005.
     

     >> Share

     
     
171. BOHULA EA, Landzberg MJ, Menon V, Alviar CL, et al
     Palliative and End-of-Life Care During Critical Cardiovascular Illness: A Scientific Statement From the American Heart Association.
     Circulation. 2025 May 15. doi: 10.1161/CIR.0000000000001334.
     

     >> Share

     
     
172. ZHANG Z, Yang X, Zhang Z
     Letter by Zhang et al Regarding Article, "Excess Mortality and Loss of Life Expectancy After Myocardial Infarction: A Registry-Based Matched Cohort Study".
     Circulation. 2025;151:e986-e987.
     

     >> Share

     
     
173. REITAN C, Andell P, Hofmann R, Jernberg T, et al
     Response by Reitan et al to Letter Regarding Article, "Excess Mortality and Loss of Life Expectancy After Myocardial Infarction: A Registry-Based Matched Cohort Study".
     Circulation. 2025;151:e988-e989.
     

     >> Share

     
     
174. WHITAKER KM, Barone Gibbs B, Hivert MF, Makarem N, et al
     Correction to: Sedentary Behavior and Light-intensity Physical Activity During Pregnancy and Cardiovascular Health: A Science Advisory From the American Heart Association.
     Circulation. 2025;151:e1000.
     

     >> Share

     
     
175. SATTAR N, Weerakkody GJ, McGuire DK, Kosiborod MN, et al
     The Association Between Tirzepatide Versus Insulin Glargine and NT-proBNP Levels in People With Type 2 Diabetes With or at Elevated Risk for Cardiovascular Disease: Post hoc Analyses of SURPASS 4.
     Circulation. 2025;151:1430-1432.
     

     >> Share

     
     April 2025
176. CLARKE R, Wright N, Lin K, Yu C, et al
     Causal Relevance of Lp(a) for Coronary Heart Disease and Stroke Types in East Asian and European Ancestry Populations: A Mendelian Randomization Study.
     Circulation. 2025 Apr 29. doi: 10.1161/CIRCULATIONAHA.124.072086.
     

     >> Share

     
     
177. BROWN TM, Pack QR, Aberegg E, Brewer LC, et al
     Correction to: Core Components of Cardiac Rehabilitation Programs: 2024 Update: A Scientific Statement From the American Heart Association and the American Association of Cardiovascular and Pulmonary Rehabilitation.
     Circulation. 2025;151:e965-e966.
     

     >> Share

     
     
178. DONG J, Yang X, Zhang W
     Letter by Dong et al Regarding Article, "Comparative Cardiovascular Effectiveness of Empagliflozin Versus Dapagliflozin in Adults With Treated Type 2 Diabetes: A Target Trial Emulation".
     Circulation. 2025;151:e962-e963.
     

     >> Share

     
     
179. BONNESEN K, Heide-Jorgensen U, Schmidt M
     Response by Bonnesen et al to Letter Regarding Article, "Comparative Cardiovascular Effectiveness of Empagliflozin Versus Dapagliflozin in Adults With Treated Type 2 Diabetes: A Target Trial Emulation".
     Circulation. 2025;151:e964.
     

     >> Share

     
     
180. ISMAHIL MA, Zhou G, Rajasekar S, Gao M, et al
     Splenic CD169(+)Tim4(+) Marginal Metallophilic Macrophages Are Essential for Wound Healing After Myocardial Infarction.
     Circulation. 2025 Apr 28. doi: 10.1161/CIRCULATIONAHA.124.071772.
     

     >> Share

     
     
181. LV H, Wang C, Liu Z, Quan M, et al
     Suppression of the Prostaglandin I2-Type 1 Interferon Axis Induces Extramedullary Hematopoiesis to Promote Cardiac Repair After Myocardial Infarction.
     Circulation. 2025 Apr 28. doi: 10.1161/CIRCULATIONAHA.124.069420.
     

     >> Share

     
     
182. BERRY JD, Zabad N, Kyrouac D, Leonard D, et al
     High-Volume Physical Activity and Clinical Coronary Artery Disease Outcomes: Findings From the Cooper Center Longitudinal Study.
     Circulation. 2025 Apr 21. doi: 10.1161/CIRCULATIONAHA.124.070335.
     

     >> Share

     
     
183. GRAVEN LJ, Kitko L, Abshire Saylor M, Allen L, et al
     Palliative Care and Advanced Cardiovascular Disease in Adults: Not Just End-of-Life Care: A Scientific Statement From the American Heart Association.
     Circulation. 2025 Apr 17. doi: 10.1161/CIR.0000000000001323.
     

     >> Share

     
     
184. STAMATAKIS E, Biswas RK, Koemel NA, Sabag A, et al
     Dose Response of Incidental Physical Activity Against Cardiovascular Events and Mortality.
     Circulation. 2025;151:1063-1075.
     

     >> Share

     
     
185. WHITAKER KM, Barone Gibbs B, Hivert MF, Makarem N, et al
     Sedentary Behavior and Light-Intensity Physical Activity During Pregnancy and Cardiovascular Health: A Science Advisory From the American Heart Association.
     Circulation. 2025 Apr 10. doi: 10.1161/CIR.0000000000001316.
     

     >> Share

     
     
186. CHEN Q, Zheng A, Xu X, Shi Z, et al
     Nrf3-Mediated Mitochondrial Superoxide Promotes Cardiomyocyte Apoptosis and Impairs Cardiac Functions by Suppressing Pitx2.
     Circulation. 2025;151:1024-1046.
     

     >> Share

     
     
187. LAM NT, Nguyen NUN, Elhelaly WM, Hsu CC, et al
     Induced Cytokinesis Generates Highly Proliferative Mononuclear Cardiomyocytes at the Expense of Contractility.
     Circulation. 2025;151:1009-1023.
     

     >> Share

     
     
188. BENOWITZ NL
     Predicting Cardiovascular Risk With Use of Various Tobacco Products.
     Circulation. 2025;151:1006-1008.
     

     >> Share

     
     
189. STEG PG, Szarek M, Jukema JW, Bhatt DL, et al
     Relation of Low-Density Lipoprotein Cholesterol, High-Sensitivity C-Reactive Protein, and Lipoprotein(a) Each to Future Cardiovascular Events and Death After Acute Coronary Syndrome on High-Intensity Statin Therapy: An Analysis of the Placebo Arm of O
     Circulation. 2025;151:1047-1050.
     

     >> Share

     
     
190. POWELL-WILEY TM, Brewer LC, Burke LE, Hernandez R, et al
     Role of Technology in Promoting Heart Healthy Behavior Change to Increase Equity in Optimal Cardiovascular Health: A Scientific Statement From the American Heart Association.
     Circulation. 2025 Apr 7. doi: 10.1161/CIR.0000000000001314.
     

     >> Share

     
     
191. SITTICHOKKANANON A, Garfield V, Chiesa ST
     Genetic and Lifestyle Risks for Coronary Artery Disease and Long-Term Risk of Incident Dementia Subtypes.
     Circulation. 2025 Apr 4. doi: 10.1161/CIRCULATIONAHA.124.070632.
     

     >> Share

     
     
192. RAO SV, O'Donoghue ML, Ruel M, Rab T, et al
     Correction to: 2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
     Circulation. 2025;151:e865.
     

     >> Share

     
     
193. KIM JH, Baggish AL, Levine BD, Ackerman MJ, et al
     Correction to: Clinical Considerations for Competitive Sports Participation for Athletes With Cardiovascular Abnormalities: A Scientific Statement From the American Heart Association and American College of Cardiology.
     Circulation. 2025;151:e864.
     

     >> Share

     
     
194. YU M, Cheng X
     Response by Yu and Cheng to Letter Regarding Article, "Effect of Colchicine on Coronary Plaque Stability in Acute Coronary Syndrome as Assessed by Optical Coherence Tomography: The COLOCT Randomized Clinical Trial".
     Circulation. 2025;151:e769-e770.
     

     >> Share

     
     
195. KAKIZAKI R, Raber L
     Letter by Kakizaki and Raber Regarding Article, "Effect of Colchicine on Coronary Plaque Stability in Acute Coronary Syndrome as Assessed by Optical Coherence Tomography: The COLOCT Randomized Clinical Trial".
     Circulation. 2025;151:e767-e768.
     

     >> Share

     
     March 2025
196. MARX N, Deanfield JE, Mann JFE, Arechavaleta R, et al
     Oral Semaglutide and Cardiovascular Outcomes in Persons With Type 2 Diabetes, According to SGLT2i Use: Prespecified Analyses of the SOUL Randomized Trial.
     Circulation. 2025 Mar 29. doi: 10.1161/CIRCULATIONAHA.125.074545.
     

     >> Share

     
     
197. BAIREY MERZ CN, Bonow RO, Carnethon M, Crea F, et al
     Role of Cardiovascular Disease Journals in Reporting Sex and Gender in Research.
     Circulation. 2025 Mar 28. doi: 10.1161/CIRCULATIONAHA.125.074517.
     

     >> Share

     
     
198. RYAN TD, Bates JE, Kinahan KE, Leger KJ, et al
     Cardiovascular Toxicity in Patients Treated for Childhood Cancer: A Scientific Statement From the American Heart Association.
     Circulation. 2025 Mar 19. doi: 10.1161/CIR.0000000000001308.
     

     >> Share

     
     
199. NDUMELE CE, Ferdinand KC, Khan SS
     The Role of Race in Cardiovascular Disease Risk Prediction.
     Circulation. 2025;151:741-743.
     

     >> Share

     
     
200. HULL LE, Aday AW, Bui QM, Luzum JA, et al
     Direct-to-Consumer Genetic Testing for Cardiovascular Disease: A Scientific Statement From the American Heart Association.
     Circulation. 2025 Mar 13. doi: 10.1161/CIR.0000000000001304.
     

     >> Share

     
     
201. KURAMITSU S, Kawase Y, Shinozaki T, Domei T, et al
     Prevalence and Clinical Outcomes of Discordant Lesions Between Fractional Flow Reserve and Nonhyperemic Pressure Ratios in Clinical Practice: The J-PRIDE Registry.
     Circulation. 2025;151:672-685.
     

     >> Share

     
     
202. PAPATHEODOROU E, Aengevaeren VL, Eijsvogels TMH, AlFakih K, et al
     Correction to: Prevalence of Coronary Atherosclerosis in Female Masters Endurance Athletes.
     Circulation. 2025;151:e709.
     

     >> Share

     
     
203. CLAUDEL SE, Verma A
     Albuminuria in Cardiovascular, Kidney, and Metabolic Disorders: A State-of-the-Art Review.
     Circulation. 2025;151:716-732.
     

     >> Share

     
     
204. ARUNOTHAYARAJ S, Egred M, Banning AP, Brunel P, et al
     Stepwise Provisional Versus Systematic Dual-Stent Strategies for Treatment of True Left Main Coronary Bifurcation Lesions.
     Circulation. 2025;151:612-622.
     

     >> Share

     
     
205. KOU S, Lu Z, Deng D, Ye M, et al
     Activation of Imprinted Gene PW1 Promotes Cardiac Fibrosis After Ischemic Injury.
     Circulation. 2025;151:623-639.
     

     >> Share

     
     February 2025
206. RAO SV, O'Donoghue ML, Ruel M, Rab T, et al
     2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
     Circulation. 2025 Feb 27. doi: 10.1161/CIR.0000000000001309.
     

     >> Share

     
     
207. 
     Correction to: Abstract 4139285: Awareness of Myocardial Infarction and Stroke Symptoms Among Asian American Adults: Insights from the National Health Interview Survey 2014 and 2017.
     Circulation. 2025;151:e681.
     

     >> Share

     
     
208. 
     Correction to: Abstract 4139303: Temporal Trends in Cardiovascular Risk Factors and Cardiovascular Disease among Middle Eastern Immigrants in the National Health Interview Survey 2004-2018.
     Circulation. 2025;151:e680.
     

     >> Share

     
     
209. STARK AW, Matthey-de-l'Endroit RL, Ferroni A, Kakizaki R, et al
     Coronary CT Anatomy-Based Prediction of Invasively Assessed Hemodynamic Significance in Middle-Aged Patients With Right Coronary Artery Anomaly: The NARCO Study.
     Circulation. 2025;151:578-580.
     

     >> Share

     
     
210. KIM JH, Baggish AL, Levine BD, Ackerman MJ, et al
     Clinical Considerations for Competitive Sports Participation for Athletes With Cardiovascular Abnormalities: A Scientific Statement From the American Heart Association and American College of Cardiology.
     Circulation. 2025 Feb 20. doi: 10.1161/CIR.0000000000001297.
     

     >> Share

     
     
211. ARMILLOTTA M, Bergamaschi L, Paolisso P, Belmonte M, et al
     Prognostic Relevance of Type 4a Myocardial Infarction and Periprocedural Myocardial Injury in Patients With Non-ST-Segment-Elevation Myocardial Infarction.
     Circulation. 2025 Feb 19. doi: 10.1161/CIRCULATIONAHA.124.070729.
     

     >> Share

     
     
212. NELLIPUDI JA, Kelly B, Hardikar A
     Addressing Cardiovascular Health Inequities in Indigenous Women: Insights from Australia and Global Perspectives.
     Circulation. 2025;151:427-429.
     

     >> Share

     
     
213. WINDFELD-MATHIASEN J, Heerfordt IM, Dalhoff KP, Traerup Andersen J, et al
     Cardiovascular Disease in Anabolic Androgenic Steroid Users.
     Circulation. 2025 Feb 13. doi: 10.1161/CIRCULATIONAHA.124.071117.
     

     >> Share

     
     
214. KIM SM, Kim S, Kim YJ, Kim WY, et al
     Major Adverse Cardiovascular Events 1 Year After Discharge in Out-of-Hospital Cardiac Arrest Survivors.
     Circulation. 2025;151:421-423.
     

     >> Share

     
     
215. BRENNAN SO, Kelly PJ, Gorey S, Synnott P, et al
     Genetically Predicted IL-18 Inhibition and Risk of Cardiovascular Events: A Mendelian Randomization Study.
     Circulation. 2025;151:334-336.
     

     >> Share

     
     January 2025
216. DAI J, Zhao J, Xu X, Chen Y, et al
     Long-Term Prognostic Implications of Non-Culprit Lesions in Patients Presenting With an Acute Myocardial Infarction: Is It the Angiographic Stenosis Severity or the Underlying High-Risk Morphology?
     Circulation. 2025 Jan 31. doi: 10.1161/CIRCULATIONAHA.124.071855.
     

     >> Share

     
     
217. HALL EJ, Agarwal S, Cullum CM, Sinha SS, et al
     Survivorship After Cardiogenic Shock.
     Circulation. 2025;151:257-271.
     

     >> Share

     
     
218. SINGER Z, Wijeysundera HC, Qiu F, Fang J, et al
     Driving Restrictions and Incapacitation Vulnerability Evaluation After ST-Segment-Elevation Myocardial Infarction: DRIVE-STEMI Study.
     Circulation. 2025;151:282-284.
     

     >> Share

     
     
219. 
     Correction to: Comparative Cardiovascular Effectiveness of Empagliflozin Versus Dapagliflozin in Adults With Treated Type 2 Diabetes: A Target Trial Emulation.
     Circulation. 2025;151:e30.
     

     >> Share

     
     
220. MAURICIO R, Sharma G, Lewey J, Tompkins R, et al
     Assessing and Addressing Cardiovascular and Obstetric Risks in Patients Undergoing Assisted Reproductive Technology: A Scientific Statement From the American Heart Association.
     Circulation. 2025 Jan 15. doi: 10.1161/CIR.0000000000001292.
     

     >> Share

     
     
221. CHEN JZ, Liang Y, Liang B
     Letter by Chen et al Regarding Article, "Piezo1-Mediated Neurogenic Inflammatory Cascade Exacerbates Ventricular Remodeling After Myocardial Infarction".
     Circulation. 2025;151:e22.
     

     >> Share

     
     
222. SUN M, He S, Hu J, Zhang Y, et al
     Response by Sun et al to Letter Regarding Article, "Piezo1-Mediated Neurogenic Inflammatory Cascade Exacerbates Ventricular Remodeling After Myocardial Infarction".
     Circulation. 2025;151:e23.
     

     >> Share

     
     
223. SIDIQI AW, Dad Zada D, Exeer NA
     Global Rounds Afghanistan: A Critical Overview of Cardiovascular Medicine.
     Circulation. 2025;151:129-131.
     

     >> Share

     
     
224. ROGNE T, Gill D
     Adverse Pregnancy Outcomes and Coronary Artery Disease Risk: A Negative Control Mendelian Randomization Study.
     Circulation. 2025;151:193-195.
     

     >> Share

     
     
225. LIU S, Deshmukh V, Meng F, Wang Y, et al
     Microtubules Sequester Acetylated YAP in the Cytoplasm and Inhibit Heart Regeneration.
     Circulation. 2025;151:59-75.
     

     >> Share

     
     
226. CHEW NWS, Mehta A, Goh RSJ, Zhang A, et al
     Cardiovascular-Liver-Metabolic Health: Recommendations in Screening, Diagnosis, and Management of Metabolic Dysfunction-Associated Steatotic Liver Disease in Cardiovascular Disease via Modified Delphi Approach.
     Circulation. 2025;151:98-119.
     

     >> Share

     
     December 2024
227. TOMII D, Pilgrim T, Borger MA, De Backer O, et al
     Aortic Stenosis and Coronary Artery Disease: Decision-Making Between Surgical and Transcatheter Management.
     Circulation. 2024;150:2046-2069.
     

     >> Share

     
     
228. ZWECK E, Hassager C, Beske RP, Jensen LO, et al
     Microaxial Flow Pump Use and Renal Outcomes in Infarct-Related Cardiogenic Shock: A Secondary Analysis of the DanGer Shock Trial.
     Circulation. 2024;150:1990-2003.
     

     >> Share

     
     
229. BIRKENFELD AL, Franks PW, Mohan V
     Precision Medicine in People at Risk for Diabetes and Atherosclerotic Cardiovascular Disease: A Fresh Perspective on Prevention.
     Circulation. 2024;150:1910-1912.
     

     >> Share

     
     
230. LEWANDOWSKI AJ, Rutter MK, Collins R
     Scientific and Clinical Impacts of UK Biobank in Cardiovascular Medicine.
     Circulation. 2024;150:1907-1909.
     

     >> Share

     
     
231. JONE PN, Tremoulet A, Choueiter N, Dominguez SR, et al
     Update on Diagnosis and Management of Kawasaki Disease: A Scientific Statement From the American Heart Association.
     Circulation. 2024;150:e481-e500.
     

     >> Share

     
     
232. DENNISON HIMMELFARB CR, Benowitz NL, Blank MD, Bhatnagar A, et al
     Impact of Smokeless Oral Nicotine Products on Cardiovascular Disease: Implications for Policy, Prevention, and Treatment: A Policy Statement From the American Heart Association.
     Circulation. 2024 Dec 3. doi: 10.1161/CIR.0000000000001293.
     

     >> Share

     
     
233. LINDNER JR, Morello M
     In Vivo Cardiovascular Molecular Imaging: Contributions to Precision Medicine and Drug Development.
     Circulation. 2024;150:1885-1897.
     

     >> Share

     
     
234. ARMBRUSTER S, Skali H, Wei LJ
     Pitfalls of Choosing a Study End Point Including Cardiovascular Death in Comparative Clinical Trials.
     Circulation. 2024;150:1823-1825.
     

     >> Share

     
     November 2024
235. QIN D, Modanwal R, Kitsis RN
     Extracellular Role for the Intracellular Cell Death Mediator RIPK3 in Myocardial Infarction.
     Circulation. 2024;150:1812-1814.
     

     >> Share

     
     
236. ZHANG W, Zhang J, Wang Z, Li T, et al
     Extracellular RIPK3 Acts as a Damage-Associated Molecular Pattern to Exaggerate Cardiac Ischemia/Reperfusion Injury.
     Circulation. 2024;150:1791-1811.
     

     >> Share

     
     
237. ITZHAKI BEN ZADOK O, Simitsis P, Jacobson C, Nadeem O, et al
     Cardiovascular Complications and Their Association With Short- and Long-Term Outcomes in Patients With Multiple Myeloma and Lymphoma Undergoing Chimeric Antigen Receptor T-Cell Therapy.
     Circulation. 2024;150:1815-1817.
     

     >> Share

     
     
238. JI Y, Zhang MJ, Wang W, Norby FL, et al
     Association of Coagulation Factor XI Level With Cardiovascular Events and Cardiac Function in Community-Dwelling Adults: From ARIC and CHS.
     Circulation. 2024 Nov 21. doi: 10.1161/CIRCULATIONAHA.124.070278.
     

     >> Share

     
     
239. MORROW A, Young R, Abraham GR, Hoole S, et al
     Zibotentan in Microvascular Angina: A Randomized, Placebo-Controlled, Crossover Trial.
     Circulation. 2024;150:1671-1683.
     

     >> Share

     
     
240. 
     Correction to: 2024 AHA/ACC/ACS/ASNC/HRS/SCA/SCCT/SCMR/SVM Guideline for Perioperative Cardiovascular Management for Noncardiac Surgery: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Gui
     Circulation. 2024;150:e466.
     

     >> Share

     
     
241. GIUGNI FR, Berry JD, Khera A, Shah AM, et al
     Precision Medicine for Cardiovascular Prevention and Population Health: A Bridge Too Far?
     Circulation. 2024;150:1720-1731.
     

     >> Share

     
     
242. HO FK, Mark PB, Lees JS, Pell JP, et al
     A Proteomics-Based Approach for Prediction of Different Cardiovascular Diseases and Dementia.
     Circulation. 2024 Nov 14. doi: 10.1161/CIRCULATIONAHA.124.070454.
     

     >> Share

     
     
243. GREIF R, Bray JE, Djarv T, Drennan IR, et al
     2024 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations: Summary From the Basic Life Support; Advanced Life Support; Pediatric Life Support; Neonatal Life Support; Educatio
     Circulation. 2024 Nov 14. doi: 10.1161/CIR.0000000000001288.
     

     >> Share

     
     
244. XU X, Zhu H, Xu K
     Letter by Xu et al Regarding Article, "Postprocedural Anticoagulation After Primary Percutaneous Coronary Intervention for ST-Segment-Elevation Myocardial Infarction: A Multicenter, Randomized, Double-Blind Trial".
     Circulation. 2024;150:e444.
     

     >> Share

     
     
245. LIANG Y, Liang B
     Letter by Y. Liang and B. Liang Regarding Article, "Postprocedural Anticoagulation After Primary Percutaneous Coronary Intervention for ST-Segment-Elevation Myocardial Infarction: A Multicenter, Randomized, Double-Blind Trial".
     Circulation. 2024;150:e443.
     

     >> Share

     
     
246. YAN Y, Nie S, Montalescot G
     Response by Yan et al to Letter Regarding Article, "Postprocedural Anticoagulation After Primary Percutaneous Coronary Intervention for ST-Segment-Elevation Myocardial Infarction: A Multicenter, Randomized, Double-Blind Trial".
     Circulation. 2024;150:e445-e446.
     

     >> Share

     
     
247. DEZFULIAN C, McCallin TE, Bierens J, Dunne CL, et al
     2024 American Heart Association and American Academy of Pediatrics Focused Update on Special Circumstances: Resuscitation Following Drowning: An Update to the American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardio
     Circulation. 2024 Nov 12. doi: 10.1161/CIR.0000000000001274.
     

     >> Share

     
     
248. KIM Y, Landstrom AP, Shah SH, Wu JC, et al
     Gene Therapy in Cardiovascular Disease: Recent Advances and Future Directions in Science: A Science Advisory From the American Heart Association.
     Circulation. 2024 Nov 11. doi: 10.1161/CIR.0000000000001296.
     

     >> Share

     
     
249. MA C, Ge J, Han Y
     Global Rounds: Advancing Cardiovascular Health in China.
     Circulation. 2024 Nov 7. doi: 10.1161/CIRCULATIONAHA.124.071544.
     

     >> Share

     
     
250. AVERBUCH T, Stelkia K, Van Spall HGC
     Cardiovascular Care in Canada: Strengths, Challenges, and Opportunities For Improvement.
     Circulation. 2024;150:1490-1492.
     

     >> Share

     
     
251. BHATIA HS, Wandel S, Willeit P, Lesogor A, et al
     Independence of Lipoprotein(a) and Low-Density Lipoprotein Cholesterol-Mediated Cardiovascular Risk: A Participant-Level Meta-Analysis.
     Circulation. 2024 Nov 4. doi: 10.1161/CIRCULATIONAHA.124.069556.
     

     >> Share

     
     
252. DILLON HT, Saner NJ, Ilsley T, Kliman DS, et al
     Preventing Allogeneic Stem Cell Transplant-Related Cardiovascular Dysfunction: ALLO-Active Trial.
     Circulation. 2024 Nov 4. doi: 10.1161/CIRCULATIONAHA.124.070709.
     

     >> Share

     
     October 2024
253. VAN DIEPEN S, Poss J, Senaratne JM, Gage A, et al
     Mixed Cardiogenic Shock: A Proposal for Standardized Classification, a Hemodynamic Definition, and Framework for Management.
     Circulation. 2024;150:1459-1468.
     

     >> Share

     
     
254. PAPATHEODOROU E, Aengevaeren VL, Eijsvogels TMH, AlFakih K, et al
     Prevalence of Coronary Atherosclerosis in Female Masters Endurance Athletes.
     Circulation. 2024;150:1478-1480.
     

     >> Share

     
     
255. GRAGNANO F, van Klaveren D, Heg D, Raber L, et al
     Derivation and Validation of the PRECISE-HBR Score to Predict Bleeding After Percutaneous Coronary Intervention.
     Circulation. 2024 Oct 27. doi: 10.1161/CIRCULATIONAHA.124.072009.
     

     >> Share

     
     
256. FOLEY MJ, Rajkumar CA, Ahmed-Jushuf F, Simader F, et al
     Fractional Flow Reserve and Instantaneous Wave-Free Ratio as Predictors of the Placebo-Controlled Response to Percutaneous Coronary Intervention in Stable Coronary Artery Disease.
     Circulation. 2024 Oct 27. doi: 10.1161/CIRCULATIONAHA.124.072281.
     

     >> Share

     
     
257. SELLKE FW
     Bleeding After Cardiovascular Surgery: A Continuing Problem.
     Circulation. 2024;150:1324-1326.
     

     >> Share

     
     
258. RUEL M, de Lemos J, Fischbein M, Hill JA, et al
     Introduction to the 2024 Cardiovascular Surgery-Themed Issue of Circulation.
     Circulation. 2024;150:1307.
     

     >> Share

     
     
259. HOFMANN C, Serafin A, Schwerdt OM, Fischer J, et al
     Transient Inhibition of Translation Improves Cardiac Function After Ischemia/Reperfusion by Attenuating the Inflammatory Response.
     Circulation. 2024;150:1248-1267.
     

     >> Share

     
     
260. SILBERNAGEL G, Chen YQ, Li H, Lemen D, et al
     Associations of Circulating ANGPTL3, C-Terminal Domain-Containing ANGPTL4, and ANGPTL3/8 and ANGPTL4/8 Complexes with LPL Activity, Diabetes, Inflammation, and Cardiovascular Mortality.
     Circulation. 2024 Oct 11. doi: 10.1161/CIRCULATIONAHA.124.069272.
     

     >> Share

     
     
261. KRISTENSEN JH, Hasselbalch RB, Strandkjaer N, Jorgensen N, et al
     Half-Life and Clearance of Cardiac Troponin I and Troponin T in Humans.
     Circulation. 2024;150:1187-1198.
     

     >> Share

     
     
262. SINNAEVE PR, Welsh RC, Arias Mendoza A, Ristic AD, et al
     Half-Dose Tenecteplase or Primary Percutaneous Coronary Intervention in Older Patients With ST-Elevation Myocardial Infarction: STREAM-2 1-Year Mortality Follow-Up.
     Circulation. 2024;150:1151-1153.
     

     >> Share

     
     
263. RUEL M, Chikwe J
     Coronary Artery Bypass Grafting: Past and Future.
     Circulation. 2024;150:1067-1069.
     

     >> Share

     
     
264. KNEUER JM, Grajek IA, Winkler M, Erbe S, et al
     Novel Long Noncoding RNA HEAT4 Affects Monocyte Subtypes, Reducing Inflammation and Promoting Vascular Healing.
     Circulation. 2024;150:1101-1120.
     

     >> Share

     
     September 2024
265. ZHAO X, Williamson T, Gong Y, Epstein JA, et al
     Immunomodulatory Therapy for Ischemic Heart Disease.
     Circulation. 2024;150:1050-1058.
     

     >> Share

     
     
266. DUAN Z, Huang Z, Lei W, Zhang K, et al
     Bone Morphogenetic Protein 9 Protects Against Myocardial Infarction by Improving Lymphatic Drainage Function and Triggering DECR1-Mediated Mitochondrial Bioenergetics.
     Circulation. 2024 Sep 24. doi: 10.1161/CIRCULATIONAHA.123.065935.
     

     >> Share

     
     
267. GIACOPPO D, Laudani C, Occhipinti G, Spagnolo M, et al
     Response by Giacoppo et al to Letter Regarding Article "Coronary Angiography, Intravascular Ultrasound, and Optical Coherence Tomography for Guiding of Percutaneous Coronary Intervention: A Systematic Review and Network Meta-Analysis".
     Circulation. 2024;150:e271-e272.
     

     >> Share

     
     
268. ZHANG Z
     Letter by Zhang Regarding Article, "Coronary Angiography, Intravascular Ultrasound, and Optical Coherence Tomography for Guiding of Percutaneous Coronary Intervention: A Systematic Review and Network Meta-Analysis".
     Circulation. 2024;150:e269-e270.
     

     >> Share

     
     
269. KOTWAL SS, Perkovic V
     Kidney Disease as a Cardiovascular Disease Priority.
     Circulation. 2024;150:975-977.
     

     >> Share

     
     
270. THOMPSON A, Fleischmann KE, Smilowitz NR, de Las Fuentes L, et al
     2024 AHA/ACC/ACS/ASNC/HRS/SCA/SCCT/SCMR/SVM Guideline for Perioperative Cardiovascular Management for Noncardiac Surgery: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
     Circulation. 2024 Sep 24. doi: 10.1161/CIR.0000000000001285.
     

     >> Share

     
     
271. BROWN TM, Pack QR, Aberegg E, Brewer LC, et al
     Core Components of Cardiac Rehabilitation Programs: 2024 Update: A Scientific Statement From the American Heart Association and the American Association of Cardiovascular and Pulmonary Rehabilitation.
     Circulation. 2024 Sep 24. doi: 10.1161/CIR.0000000000001289.
     

     >> Share

     
     
272. LEE DH
     Microplastics and Cardiovascular Diseases: Importance of Coexisting Environmental Pollutants.
     Circulation. 2024;150:908-910.
     

     >> Share

     
     
273. SHAH NS, Kandula NR, Commodore-Mensah Y, Morey BN, et al
     Social Determinants of Cardiovascular Health in Asian Americans: A Scientific Statement From the American Heart Association.
     Circulation. 2024 Sep 16. doi: 10.1161/CIR.0000000000001278.
     

     >> Share

     
     
274. BUTALA NM, Bucholz EM
     Quantifying Longevity After Myocardial Infarction: What Is Lost and What Is Gained.
     Circulation. 2024;150:836-837.
     

     >> Share

     
     
275. BEI Y, Zhu Y, Zhou J, Ai S, et al
     Inhibition of Hmbox1 Promotes Cardiomyocyte Survival and Glucose Metabolism Through Gck Activation in Ischemia/Reperfusion Injury.
     Circulation. 2024;150:848-866.
     

     >> Share

     
     
276. DIWAN A
     The Case for Restoring Organelles to Treat Ischemic Cardiomyopathy: Is DEPP1 an Attractive Target?
     Circulation. 2024;150:787-790.
     

     >> Share

     
     
277. WYANT GA, Jiang Q, Singh M, Qayyum S, et al
     Induction of DEPP1 by HIF Mediates Multiple Hallmarks of Ischemic Cardiomyopathy.
     Circulation. 2024;150:770-786.
     

     >> Share

     
     
278. VOLPP KG
     Using Behavioral Science to Improve Cardiovascular Health.
     Circulation. 2024;150:743-745.
     

     >> Share

     
     
279. SIMON T, Herbert BM, Brooks MM, Goodman SG, et al
     Restrictive or Liberal Transfusion Strategy in Patients With Acute Myocardial Infarction and Anemia: 6-Month Mortality in the MINT Trial.
     Circulation. 2024 Sep 2. doi: 10.1161/CIRCULATIONAHA.124.069917.
     

     >> Share

     
     
280. CAMPO G, Bohm F, Engstrom T, Smits PC, et al
     Complete vs. Culprit-Only Revascularization in Older Patients with ST-segment Elevation Myocardial Infarction: An Individual Patient Meta-Analysis.
     Circulation. 2024 Sep 1. doi: 10.1161/CIRCULATIONAHA.124.071493.
     

     >> Share

     
     August 2024
281. BODEN WE, De Caterina R, Kaski JC, Bairey Merz CN, et al
     Myocardial Ischemic Syndromes: A New Nomenclature to Harmonize Evolving International Clinical Practice Guidelines.
     Circulation. 2024 Aug 30. doi: 10.1161/CIRCULATIONAHA.123.065656.
     

     >> Share

     
     
282. NEUEN BL, Fletcher RA, Heath L, Perkovic A, et al
     Cardiovascular, Kidney and Safety Outcomes with GLP-1 Receptor Agonists Alone and in Combination with SGLT2 Inhibitors in Type 2 Diabetes: A Systematic Review and Meta-Analysis.
     Circulation. 2024 Aug 30. doi: 10.1161/CIRCULATIONAHA.124.071689.
     

     >> Share

     
     
283. DEFILIPPIS AP, Abbott JD, Herbert BM, Bertolet MH, et al
     Restrictive Versus Liberal Transfusion in Patients with Type 1 or Type 2 Myocardial Infarction: A Prespecified Analysis of the Myocardial Ischemia and Transfusion (MINT) Trial.
     Circulation. 2024 Aug 29. doi: 10.1161/CIRCULATIONAHA.124.071208.
     

     >> Share

     
     
284. BONNESEN K, Heide-Jorgensen U, Christensen DH, Lash TL, et al
     Comparative Cardiovascular Effectiveness of Empagliflozin Versus Dapagliflozin in Adults With Treated Type 2 Diabetes: A Target Trial Emulation.
     Circulation. 2024 Aug 29. doi: 10.1161/CIRCULATIONAHA.124.068613.
     

     >> Share

     
     
285. DELWARDE C, Aikawa M
     Novel Mouse Model of Late-Stage Coronary Atherosclerosis With Features of Plaque Rupture and Stroke.
     Circulation. 2024;150:706-709.
     

     >> Share

     
     
286. LI J, Sun S, Zhu D, Mei X, et al
     Inhalable Stem Cell Exosomes Promote Heart Repair After Myocardial Infarction.
     Circulation. 2024;150:710-723.
     

     >> Share

     
     
287. YU M, Yang Y, Dong SL, Zhao C, et al
     Effect of Colchicine on Coronary Plaque Stability in Acute Coronary Syndrome as Assessed by Optical Coherence Tomography: The COLOCT Randomized Clinical Trial.
     Circulation. 2024 Aug 21. doi: 10.1161/CIRCULATIONAHA.124.069808.
     

     >> Share

     
     
288. KERN MJ, Seto AH
     Does PPG, the Other Dimension to FFR, Better Predict Post-PCI Results?
     Circulation. 2024;150:598-599.
     

     >> Share

     
     
289. KOBAYASHI H, Tohyama S, Ichimura H, Ohashi N, et al
     Regeneration of Nonhuman Primate Hearts With Human Induced Pluripotent Stem Cell-Derived Cardiac Spheroids.
     Circulation. 2024;150:611-621.
     

     >> Share

     
     
290. KOVILAKATH A, Mauro AG, Valentine YA, Raucci FJ, et al
     SPTLC3 Is Essential for Complex I Activity and Contributes to Ischemic Cardiomyopathy.
     Circulation. 2024;150:622-641.
     

     >> Share

     
     
291. ABBATE A, Van Tassell B, Bogin V, Markley R, et al
     Results of International, Double-Blind, Randomized, Placebo-Controlled, Phase IIa Study of Interleukin-1 Blockade With RPH-104 (Goflikicept) in Patients With ST-Segment-Elevation Myocardial Infarction (STEMI).
     Circulation. 2024;150:580-582.
     

     >> Share

     
     
292. MOSLEHI JJ
     Cardio-Oncology: A New Clinical Frontier and Novel Platform for Cardiovascular Investigation.
     Circulation. 2024;150:513-515.
     

     >> Share

     
     
293. MORRIS SA, Flyer JN, Yetman AT, Quezada E, et al
     Cardiovascular Management of Aortopathy in Children: A Scientific Statement From the American Heart Association.
     Circulation. 2024 Aug 12. doi: 10.1161/CIR.0000000000001265.
     

     >> Share

     
     
294. LIN Y, Gil CH, Banno K, Yokoyama M, et al
     ABCG2-Expressing Clonal Repopulating Endothelial Cells Serve to Form and Maintain Blood Vessels.
     Circulation. 2024;150:451-465.
     

     >> Share

     
     
295. BITTNER V
     Eicosapentanoic Acid Supplementation for Atherosclerotic Cardiovascular Disease Prevention.
     Circulation. 2024;150:435-438.
     

     >> Share

     
     
296. JOYNT MADDOX KE
     Health Economics of Cardiovascular Disease in the United States.
     Circulation. 2024;150:419-421.
     

     >> Share

     
     
297. MARTINEZ-MORATA I, Schilling K, Glabonjat RA, Domingo-Relloso A, et al
     Association of Urinary Metals With Cardiovascular Disease Incidence and All-Cause Mortality in the Multi-Ethnic Study of Atherosclerosis (MESA).
     Circulation. 2024 Aug 1. doi: 10.1161/CIRCULATIONAHA.124.069414.
     

     >> Share

     
     July 2024
298. 
     Correction to: 2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
     Circulation. 2024;150:e105.
     

     >> Share

     
     
299. VALGIMIGLI M, Landi A, Angiolillo DJ, Baber U, et al
     Demystifying the Contemporary Role of 12-Month Dual Antiplatelet Therapy After Acute Coronary Syndrome.
     Circulation. 2024;150:317-335.
     

     >> Share

     
     
300. ARMSTRONG PW
     Global Collaborative Cardiovascular Research: The Collective Wisdom of Countries.
     Circulation. 2024;150:258-260.
     

     >> Share

     
     
301. GRANT JK, Martin SS, Zhang S, Matsushita K, et al
     Racial Differences in the Burden of Atherosclerotic Cardiovascular Disease Related to Elevated Lipoprotein(a) Levels: The ARIC Study.
     Circulation. 2024;150:250-252.
     

     >> Share

     
     
302. WANG Y, Chen GC, Wang Z, Luo K, et al
     Dietary Acculturation Is Associated With Altered Gut Microbiome, Circulating Metabolites, and Cardiovascular Disease Risk in US Hispanics and Latinos: Results From HCHS/SOL.
     Circulation. 2024;150:215-229.
     

     >> Share

     
     
303. SONG N, Beyene TJ, Amponsah DK, Asch SM, et al
     Novel Use of Z Codes to Identify Social Determinants of Cardiovascular Disease Outcomes.
     Circulation. 2024;150:243-245.
     

     >> Share

     
     
304. ADEDINSEWO D
     Advancing Cardiovascular Health Equity With Artificial Intelligence: A Collective Ethical Responsibility.
     Circulation. 2024;150:174-176.
     

     >> Share

     
     
305. WEYRICH M, Cremer S, Gerster M, Sarakpi T, et al
     Loss of Y Chromosome and Cardiovascular Events in Chronic Kidney Disease.
     Circulation. 2024 Jul 15. doi: 10.1161/CIRCULATIONAHA.124.069139.
     

     >> Share

     
     
306. ABBARA S, Shaw LJ
     Past, Present, and Future of CTA.
     Circulation. 2024;150:87-90.
     

     >> Share

     
     
307. FLEG JL, Huang Z, Reynolds HR, Shaw LJ, et al
     Ischemia Severity, Coronary Artery Disease Extent, and Exercise Capacity in ISCHEMIA.
     Circulation. 2024;150:165-167.
     

     >> Share

     
     
308. KUEHN BM
     Million Hearts Model Reduces Cardiovascular Events Without Increasing Care Costs.
     Circulation. 2024;150:162-164.
     

     >> Share

     
     
309. REITAN C, Andell P, Alfredsson J, Erlinge D, et al
     Excess Mortality and Loss of Life Expectancy After Myocardial Infarction: A Registry-Based Matched Cohort Study.
     Circulation. 2024 Jul 5. doi: 10.1161/CIRCULATIONAHA.124.068739.
     

     >> Share

     
     
310. BERRY C, Sidik NP, McEntegart MB
     Response by Berry et al to Letter Regarding Article, "Invasive Endotyping in Patients With Angina and No Obstructive Coronary Artery Disease: A Randomized Controlled Trial".
     Circulation. 2024;150:e5-e6.
     

     >> Share

     
     
311. NISHI T, Saito Y, Kobayashi Y
     Letter by Nishi et al Regarding Article, "Invasive Endotyping in Patients With Angina and No Obstructive Coronary Artery Disease: A Randomized Controlled Trial".
     Circulation. 2024;150:e3-e4.
     

     >> Share

     
     June 2024
312. KIM K, Joyce BT, Zheng Y, Nannini DR, et al
     Associations of Urban Blue and Green Spaces With Coronary Artery Calcification in Black Individuals and Disadvantaged Neighborhoods.
     Circulation. 2024 Jun 27. doi: 10.1161/CIRCULATIONAHA.123.067992.
     

     >> Share

     
     
313. TANNU M, Kaltenbach L, Pagidipati NJ, McGuire DK, et al
     Effects of an Intervention to Improve Evidence-Based Care for People With Diabetes and Cardiovascular Disease Across Sex, Race, and Ethnicity Subgroups: Insights From the COORDINATE-Diabetes Trial.
     Circulation. 2024 Jun 27. doi: 10.1161/CIRCULATIONAHA.124.068962.
     

     >> Share

     
     
314. LIU T, Hao Y, Zhang Z, Zhou H, et al
     Advanced Cardiac Patches for the Treatment of Myocardial Infarction.
     Circulation. 2024;149:2002-2020.
     

     >> Share

     
     
315. JHA AK
     Letter by Jha Regarding Article, "Early Left Ventricular Unloading or Conventional Approach After Venoarterial Extracorporeal Membrane Oxygenation: The EARLY-UNLOAD Randomized Clinical Trial".
     Circulation. 2024;149:e1415-e1416.
     

     >> Share

     
     
316. ZHANG S, Zhang Y, Duan X, Wang B, et al
     Targeting NPM1 Epigenetically Promotes Postinfarction Cardiac Repair by Reprogramming Reparative Macrophage Metabolism.
     Circulation. 2024;149:1982-2001.
     

     >> Share

     
     
317. SHAMSUZZAMAN S, Deaton RA, Salamon A, Doviak H, et al
     Novel Mouse Model of Myocardial Infarction, Plaque Rupture, and Stroke Shows Improved Survival With Myeloperoxidase Inhibition.
     Circulation. 2024 Jun 17. doi: 10.1161/CIRCULATIONAHA.123.067931.
     

     >> Share

     
     
318. MIYAUCHI K, Iwata H, Nishizaki Y, Inoue T, et al
     Randomized Trial for Evaluation in Secondary Prevention Efficacy of Combination Therapy-Statin and Eicosapentaenoic Acid (RESPECT-EPA).
     Circulation. 2024 Jun 14. doi: 10.1161/CIRCULATIONAHA.123.065520.
     

     >> Share

     
     
319. 
     Correction to: 2023 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations: Summary From the Basic Life Support; Advanced Life Support; Pediatric Life Support; Neonatal Life Su
     Circulation. 2024;149:e1411.
     

     >> Share

     
     
320. HUNDLEY WG
     Fifty Years of Cardiovascular Magnetic Resonance: Continuing Evolution Toward the "One-Stop Shop" for Cardiovascular Diagnosis.
     Circulation. 2024;149:1859-1861.
     

     >> Share

     
     
321. ANDREOTTI F, Burzotta F, Maggioni AP
     Letter by Andreotti et al Regarding Article, "Inflammation and Cholesterol as Predictors of Cardiovascular Events Among 13 970 Contemporary High-Risk Patients With Statin Intolerance".
     Circulation. 2024;149:e1312.
     

     >> Share

     
     
322. GURAGAIN B, Wei Y, Zhang H, Kahn-Krell A, et al
     Implanted Human Cardiac Spheroids Electrically Couple With Infarcted Swine Myocardium.
     Circulation. 2024;149:1855-1857.
     

     >> Share

     
     
323. KAZI DS, Elkind MSV, Deutsch A, Dowd WN, et al
     Forecasting the Economic Burden of Cardiovascular Disease and Stroke in the United States Through 2050: A Presidential Advisory From the American Heart Association.
     Circulation. 2024 Jun 4. doi: 10.1161/CIR.0000000000001258.
     

     >> Share

     
     
324. MORAN AE, Goldman L
     Predicting the Future Prevalence of Cardiovascular Disease: The Good, the Bad, the Known, and the Unknown.
     Circulation. 2024 Jun 4. doi: 10.1161/CIRCULATIONAHA.124.070265.
     

     >> Share

     
     
325. JOYNT MADDOX KE, Elkind MSV, Aparicio HJ, Commodore-Mensah Y, et al
     Forecasting the Burden of Cardiovascular Disease and Stroke in the United States Through 2050-Prevalence of Risk Factors and Disease: A Presidential Advisory From the American Heart Association.
     Circulation. 2024 Jun 4. doi: 10.1161/CIR.0000000000001256.
     

     >> Share

     
     May 2024
326. MEHTA LS, Churchwell K, Coleman D, Davidson J, et al
     Fostering Psychological Safety and Supporting Mental Health Among Cardiovascular Health Care Workers: A Science Advisory From the American Heart Association.
     Circulation. 2024 May 30. doi: 10.1161/CIR.0000000000001259.
     

     >> Share

     
     
327. NAKAMORI S, Amyar A, Fahmy AS, Ngo LH, et al
     Cardiovascular Magnetic Resonance Radiomics to Identify Components of the Extracellular Matrix in Dilated Cardiomyopathy.
     Circulation. 2024 May 29. doi: 10.1161/CIRCULATIONAHA.123.067107.
     

     >> Share

     
     
328. CALLER T, Rotem I, Shaihov-Teper O, Lendengolts D, et al
     Small Extracellular Vesicles From Infarcted and Failing Heart Accelerate Tumor Growth.
     Circulation. 2024;149:1729-1748.
     

     >> Share

     
     
329. ZHAI X, Cao S, Wang J, Qiao B, et al
     Carbonylation of Runx2 at K176 by 4-Hydroxynonenal Accelerates Vascular Calcification.
     Circulation. 2024;149:1752-1769.
     

     >> Share

     
     
330. 
     Correction to: 2022 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations: Summary From the Basic Life Support; Advanced Life Support; Pediatric Life Support; Neonatal Life Su
     Circulation. 2024;149:e1218.
     

     >> Share

     
     
331. SATTAR N, Neeland IJ, McGuire DK
     Obesity and Cardiovascular Disease: A New Dawn.
     Circulation. 2024;149:1621-1623.
     

     >> Share

     
     
332. ZHU Q, Scherer PE
     Ceramides and Atherosclerotic Cardiovascular Disease: A Current Perspective.
     Circulation. 2024;149:1624-1626.
     

     >> Share

     
     
333. BULLUCK H, Chong JH, Bryant J, Annathurai A, et al
     Effect of Cangrelor on Infarct Size in ST-Segment Elevation Myocardial Infarction Treated By Primary Percutaneous Coronary Intervention: A Randomized Controlled Trial (The PITRI Trial).
     Circulation. 2024 May 14. doi: 10.1161/CIRCULATIONAHA.124.068938.
     

     >> Share

     
     
334. COLLET C, Munhoz D, Mizukami T, Sonck J, et al
     Influence of Pathophysiological Patterns of Coronary Artery Disease on Immediate Percutaneous Coronary Intervention Outcomes.
     Circulation. 2024 May 14. doi: 10.1161/CIRCULATIONAHA.124.069450.
     

     >> Share

     
     
335. 
     Correction to: An Aspirin-Free Versus Dual Antiplatelet Strategy for Coronary Stenting: STOPDAPT-3 Randomized Trial.
     Circulation. 2024;149:e1189-e1190.
     

     >> Share

     
     
336. TANG WHW, Hazen SL
     Unraveling the Complex Relationship Between Gut Microbiome and Cardiovascular Diseases.
     Circulation. 2024;149:1543-1545.
     

     >> Share

     
     
337. MORRISON JT, Canonico ME, Anand SS, Patel MR, et al
     Low-Dose Rivaroxaban Plus Aspirin in Patients With Peripheral Artery Disease Undergoing Lower Extremity Revascularization With and Without Concomitant Coronary Artery Disease: Insights From VOYAGER PAD.
     Circulation. 2024;149:1536-1539.
     

     >> Share

     
     April 2024
338. KELHAM M, Mathur A, Jones DA
     Response by Kelham et al to Letter Regarding Article, "Computed Tomography Cardiac Angiography Before Invasive Coronary Angiography in Patients With Previous Bypass Surgery: The BYPASS-CTCA Trial".
     Circulation. 2024;149:e1133.
     

     >> Share

     
     
339. APOSTOLOS A, Karamasis GV, Tsigkas G
     Letter by Apostolos et al Regarding Article, "Computed Tomography Cardiac Angiography Before Invasive Coronary Angiography in Patients With Previous Bypass Surgery: The BYPASS-CTCA Trial".
     Circulation. 2024;149:e1132.
     

     >> Share

     
     
340. ZAMAN S, Edwards NC, Chew DP
     Global Rounds: Cardiovascular Care in Australia and New Zealand.
     Circulation. 2024;149:1402-1404.
     

     >> Share

     
     
341. SOLOMON CG, Landrigan PJ
     Fossil Fuels, Climate Change, and Cardiovascular Disease: A Call to Action.
     Circulation. 2024;149:1400-1401.
     

     >> Share

     
     
342. LEMESLE G, Lamblin N, Schurtz G, Labreuche J, et al
     Comparison of Incidence and Prognostic Impact of Ischemic Major Bleeding and Heart Failure Events in Patients With Chronic Coronary Syndrome: Insights From the CORONOR Registry.
     Circulation. 2024 Apr 25. doi: 10.1161/CIRCULATIONAHA.123.067938.
     

     >> Share

     
     
343. GIRI J, Kaneko T
     Much Ado About Nothing? CABG or PCI for Left Main Coronary Artery Disease.
     Circulation. 2024;149:1339-1340.
     

     >> Share

     
     
344. SHAH SH, Gerszten RE
     Sifting for Gold in Terabytes of Data: Illuminating Cardiovascular Biology in the 'Omics Age.
     Circulation. 2024;149:1323-1325.
     

     >> Share

     
     
345. SWAIN L, Bhave S, Qiao X, Reyelt L, et al
     Novel Role for Cardiolipin as a Target of Therapy to Mitigate Myocardial Injury Caused by Venoarterial Extracorporeal Membrane Oxygenation.
     Circulation. 2024;149:1341-1353.
     

     >> Share

     
     
346. 
     Correction to: 2023 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations: Summary From the Basic Life Support; Advanced Life Support; Pediatric Life Support; Neonatal Life Su
     Circulation. 2024;149:e1128.
     

     >> Share

     
     
347. GOLDFARB MJ, Saylor MA, Bozkurt B, Code J, et al
     Patient-Centered Adult Cardiovascular Care: A Scientific Statement From the American Heart Association.
     Circulation. 2024 Apr 11. doi: 10.1161/CIR.0000000000001233.
     

     >> Share

     
     
348. PATEL SM, Kang YM, Im K, Neuen BL, et al
     Sodium Glucose Co-transporter 2 Inhibitors and Major Adverse Cardiovascular Outcomes: A SMART-C Collaborative Meta-Analysis.
     Circulation. 2024 Apr 7. doi: 10.1161/CIRCULATIONAHA.124.069568.
     

     >> Share

     
     
349. FANAROFF AC, Patel MS, Chokshi N, Coratti S, et al
     Effect of Gamification, Financial Incentives, or Both to Increase Physical Activity Among Patients at High Risk of Cardiovascular Events: The BE ACTIVE Randomized Controlled Trial.
     Circulation. 2024 Apr 7. doi: 10.1161/CIRCULATIONAHA.124.069531.
     

     >> Share

     
     
350. HERNANDEZ AF, Udell JA, Jones WS, Anker SD, et al
     Effect of Empagliflozin on Heart Failure Outcomes After Acute Myocardial Infarction: Insights from the EMPACT-MI Trial.
     Circulation. 2024 Apr 6. doi: 10.1161/CIRCULATIONAHA.124.069217.
     

     >> Share

     
     
351. CHO L, Plutzky J, Brennan D, Louie MJ, et al
     Impact of Bempedoic Acid on Cardiovascular Outcomes by Sex.
     Circulation. 2024 Apr 6. doi: 10.1161/CIRCULATIONAHA.123.067691.
     

     >> Share

     
     
352. MAEHARA A, Sugizaki Y
     Intravascular Imaging for Guiding Percutaneous Coronary Intervention: What Does the Totality of Data Suggest, and Where Should We Go?
     Circulation. 2024;149:1087-1089.
     

     >> Share

     
     
353. BLUMER V, Kanwar MK, Barnett CF, Cowger JA, et al
     Cardiogenic Shock in Older Adults: A Focus on Age-Associated Risks and Approach to Management: A Scientific Statement From the American Heart Association.
     Circulation. 2024;149:e1051-e1065.
     

     >> Share

     
     
354. WU JC, Wilson BH, Fang JC, Hurwitz JL, et al
     Modernizing Cardiovascular Medicine Board Certification: Leveraging Innovation and Strengthening Continuous Competency and Professional Growth.
     Circulation. 2024 Apr 1. doi: 10.1161/CIRCULATIONAHA.124.069553.
     

     >> Share

     
     March 2024
355. BERG-HANSEN K, Gopalasingam N, Christensen KH, Ladefoged B, et al
     Cardiovascular Effects of Oral Ketone Ester Treatment in Patients With Heart Failure With Reduced Ejection Fraction: A Randomized, Controlled, Double-Blind Trial.
     Circulation. 2024 Mar 27. doi: 10.1161/CIRCULATIONAHA.123.067971.
     

     >> Share

     
     
356. LUSEBRINK E, Binzenhofer L, Hering D, Villegas Sierra L, et al
     Scrutinizing the Role of Venoarterial Extracorporeal Membrane Oxygenation: Has Clinical Practice Outpaced the Evidence?
     Circulation. 2024;149:1033-1052.
     

     >> Share

     
     
357. SERRUYS PW, Revaiah PC
     The American Heart Association's Centennial and Percutaneous Coronary Intervention's Semi-Centennial.
     Circulation. 2024;149:973-978.
     

     >> Share

     
     
358. FENG J, Li Y, Li Y, Yin Q, et al
     Versican Promotes Cardiomyocyte Proliferation and Cardiac Repair.
     Circulation. 2024;149:1004-1015.
     

     >> Share

     
     
359. 
     Correction to: Cardiovascular-Kidney-Metabolic Health: A Presidential Advisory From the American Heart Association.
     Circulation. 2024;149:e1023.
     

     >> Share

     
     
360. SHUEY MM, Wang Y, Xiang RR, Zou A, et al
     Aggregation and Contextualization of Murine Investigations Improves Discovery of Significant Human Atherosclerotic Cardiovascular Disease Associations.
     Circulation. 2024;149:1056-1058.
     

     >> Share

     
     
361. TENG Z, Ma Y, Ma X
     Letter by Teng et al Regarding Article, "Cardiac Pericytes Acquire a Fibrogenic Phenotype and Contribute to Vascular Maturation After Myocardial Infarction".
     Circulation. 2024;149:e960-e961.
     

     >> Share

     
     
362. FRANGOGIANNIS NG
     Response by Frangogiannis to Letter Regarding Article, "Cardiac Pericytes Acquire a Fibrogenic Phenotype and Contribute to Vascular Maturation After Myocardial Infarction".
     Circulation. 2024;149:e962-e963.
     

     >> Share

     
     
363. MARANO P, Mouapi K, Kim A, Mastali M, et al
     Apolipoproteins Quantified Using Blood Volumetric Absorptive Microsampling and High-Throughput Mass Spectrometry for Risk Assessment in Ischemic Heart Disease.
     Circulation. 2024;149:970-972.
     

     >> Share

     
     
364. EVERETT BM
     The Confusing Landscape of Cardiovascular Health Assessment, Promotion, and Prediction.
     Circulation. 2024;149:914-916.
     

     >> Share

     
     
365. LANDSTROM AP, Chahal CAA, Roden DM, Ho CY, et al
     A Customizable and Peer-Reviewed Curriculum for Cardiovascular Genetics and Genomics.
     Circulation. 2024;149:902-904.
     

     >> Share

     
     
366. JUNCA G, Delgado V
     Dual (Ischemic and Nonischemic) Cardiomyopathy: A Wolf in Sheep's Clothing.
     Circulation. 2024;149:822-824.
     

     >> Share

     
     
367. HEUTS S, Myers PO, Siepe M
     Letter by Heuts et al Regarding Article, "Fractional Flow Reserve-Guided PCI or Coronary Bypass Surgery for 3-Vessel Coronary Artery Disease: 3-Year Follow-Up of the FAME 3 Trial".
     Circulation. 2024;149:892-893.
     

     >> Share

     
     
368. RODRIGUEZ AE, Fernandez-Pereira C, Mieres J
     Letter by Rodriguez et al Regarding Article, "Fractional Flow Reserve-Guided PCI or Coronary Bypass Surgery for 3-Vessel Coronary Artery Disease: 3-Year Follow-Up of the FAME 3 Trial".
     Circulation. 2024;149:894-895.
     

     >> Share

     
     
369. ZIMMERMANN FM, Ding VY, Fearon WF
     Response by Zimmermann et al to Letter Regarding Article, "Fractional Flow Reserve-Guided PCI or Coronary Bypass Surgery for 3-Vessel Coronary Artery Disease: 3-Year Follow-Up of the FAME 3 Trial".
     Circulation. 2024;149:896.
     

     >> Share

     
     
370. HAYEK SS, Zaha VG, Bogle C, Deswal A, et al
     Cardiovascular Management of Patients Undergoing Hematopoietic Stem Cell Transplantation: From Pretransplantation to Survivorship: A Scientific Statement From the American Heart Association.
     Circulation. 2024 Mar 11. doi: 10.1161/CIR.0000000000001220.
     

     >> Share

     
     
371. GABA P, Sabik JF, Murphy SA, Bellavia A, et al
     Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting in Patients With Left Main Disease With or Without Diabetes: Findings From a Pooled Analysis of 4 Randomized Clinical Trials.
     Circulation. 2024 Mar 11. doi: 10.1161/CIRCULATIONAHA.123.065571.
     

     >> Share

     
     
372. ALEXANDER T, Kumbhani DJ, Mullasari Sankardas A
     The Future of Pharmacoinvasive Therapy for ST-Segment-Elevation Myocardial Infarction Reperfusion in the Post-STREAM Era.
     Circulation. 2024;149:732-733.
     

     >> Share

     
     
373. RAJAGOPALAN S, Brook RD
     Cardiovascular and Planetary Health: Two Sides of the Same Planet.
     Circulation. 2024;149:729-731.
     

     >> Share

     
     February 2024
374. CHEN Z, Zhang J, He Y
     Letter by Chen et al Regarding Article, "STREAM-2: Half-Dose Tenecteplase or Primary Percutaneous Coronary Intervention in Older Patients With ST-Segment-Elevation Myocardial Infarction: A Randomized, Open-Label Trial".
     Circulation. 2024;149:725-726.
     

     >> Share

     
     
375. VAN DE WERF F, Sinnaeve P, Welsh RC, Armstrong PW, et al
     Response by Van de Werf et al to Letter Regarding Article, "STREAM-2: Half-Dose Tenecteplase or Primary Percutaneous Coronary Intervention in Older Patients With ST-Segment-Elevation Myocardial Infarction: A Randomized, Open-Label Trial".
     Circulation. 2024;149:727-728.
     

     >> Share

     
     
376. GAFFEY AE, Rollman BL, Burg MM
     Strengthening the Pillars of Cardiovascular Health: Psychological Health is a Crucial Component.
     Circulation. 2024;149:641-643.
     

     >> Share

     
     
377. DZAU VJ, Hodgkinson CP
     RNA Therapeutics for the Cardiovascular System.
     Circulation. 2024;149:707-716.
     

     >> Share

     
     
378. YAN Y, Guo J, Wang X, Wang G, et al
     Postprocedural Anticoagulation After Primary Percutaneous Coronary Intervention for ST-Segment-Elevation Myocardial Infarction: A Multicenter, Randomized, Double-Blind Trial.
     Circulation. 2024 Feb 26. doi: 10.1161/CIRCULATIONAHA.123.067079.
     

     >> Share

     
     October 2023
379. GAUDINO M, Sandner S, An KR, Dimagli A, et al
     Graft Failure After Coronary Artery Bypass Grafting and Its Association With Patient Characteristics and Clinical Events: A Pooled Individual Patient Data Analysis of Clinical Trials With Imaging Follow-Up.
     Circulation. 2023;148:1305-1315.
     

     >> Share

     
     

Free Medical Abstracts
Privacy Policy
Sponsors
Share